,PARENT_MOLREGNO,CHEMBL_ID,SYNONYMS,DEVELOPMENT_PHASE,RESEARCH_CODES,APPLICANTS,USAN_STEM,USAN_STEM_DEFINITION,USAN_STEM_SUBSTEM,USAN_YEAR,FIRST_APPROVAL,ATC_CODE,ATC_CODE_DESCRIPTION,INDICATION_CLASS,SC_PATENT_NO,DRUG_TYPE,RULE_OF_FIVE,FIRST_IN_CLASS,CHIRALITY,PRODRUG,ORAL,PARENTERAL,TOPICAL,BLACK_BOX,AVAILABILITY_TYPE,WITHDRAWN_YEAR,WITHDRAWN_COUNTRY,WITHDRAWN_REASON,CANONICAL_SMILES,ROMol,FP
0,675015,CHEMBL1201064,"Fluorometholone Acetate (FDA, USAN)",4,U-17323,Alcon Laboratories Inc,-olone,steroids (not prednisolone derivatives),-olone,1984.0,1986.0,D10AA01; S01CB05; C05AA06; S01BA07; D07XB04; D07AB06,"D10AA01 [Dermatologicals:Anti-Acne Preparations:Anti-Acne Preparations For Topical Use:Corticosteroids, combinations for treatment of acne]; S01CB05 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents And Antiinfectives In Combination:Corticosteroids/antiinfectives/mydriatics in combination]; C05AA06 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; S01BA07 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; D07XB04 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, moderately potent, other combinations]; D07AB06 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, moderately potent (group II)]",Anti-Inflammatory,,Natural Product-derived,Y,N,Single Stereoisomer,Y,N,N,Y,N,Prescription-only,,,,C[C@H]1C[C@H]2[C@@H]3CC[C@](OC(=O)C)(C(=O)C)[C@@]3(C)C[C@H](O)[C@]2(F)[C@@]4(C)C=CC(=O)C=C14,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0e3f90>,[0. 0. 0. ... 0. 0. 0.]
4,246,CHEMBL9,"Norfloxacin (BAN, FDA, INN, JAN, USAN, USP)",4,MK-366,Merck Research Laboratories Div Merck Co Inc,-oxacin,antibacterials (quinolone derivatives),-oxacin,1984.0,1986.0,J01MA06; S01AE02,J01MA06 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones]; S01AE02 [Sensory Organs:Ophthalmologicals:Antiinfectives:Fluoroquinolones],Antibacterial,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,Y,Y,Prescription-only,,,,CCN1C=C(C(=O)O)C(=O)c2cc(F)c(cc12)N3CCNCC3,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0e3eb0>,[0. 0. 0. ... 0. 0. 0.]
5,139014,CHEMBL1068,"Oxcarbazepine (BAN, FDA, INN, USAN)",4,GP-47680; KIN-493,Supernus Pharmaceuticals Inc; Novartis Pharmaceuticals Corp,-pin(e),tricyclic compounds,-pin(e),2002.0,2000.0,N03AF02,N03AF02 [Nervous System:Antiepileptics:Antiepileptics:Carboxamide derivatives],,US-7037525-B2,Synthetic Small Molecule,Y,N,Achiral Molecule,Y,Y,N,N,Y,Prescription-only,,,,NC(=O)N1c2ccccc2CC(=O)c3ccccc13,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0e3e40>,[0. 0. 0. ... 0. 0. 0.]
17,14785,CHEMBL553,"Erlotinib (INN); Erlotinib HCl (FDA, INN, USAN)",4,CP-358774; OSI-774; R-1415; RG-1415; Ro-508231; CP-35877401; CP-358774-01,Osi Pharmaceuticals Inc,-tinib,tyrosine kinase inhibitors,-tinib,2001.0,2004.0,L01XE03,L01XE03 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors],,US-5747498-A,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,N,N,Prescription-only,,,,COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOC,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0e3cf0>,[0. 0. 0. ... 0. 0. 0.]
35,147956,CHEMBL1086,"Cinchocaine (BAN, INN); Dibucaine (USP); Cinchocaine HCl (BAN); Dibucaine HCl (FDA, JAN, USP)",4,,Novartis Pharmaceuticals Corp; Ciba-Geigy,-caine,local anesthetics,-caine,,1982.0,C05AD04; S01HA06; S02DA04; D04AB02; N01BB06,"C05AD04 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Local anesthetics]; S01HA06 [Sensory Organs:Ophthalmologicals:Local Anesthetics:Local anesthetics]; S02DA04 [Sensory Organs:Otologicals:Other Otologicals:Analgesics and anesthetics]; D04AB02 [Dermatologicals:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Anesthetics for topical use]; N01BB06 [Nervous System:Anesthetics:Anesthetics, Local:Amides]",Anesthetic (local),,Synthetic Small Molecule,Y,N,Achiral Molecule,N,N,Y,N,N,Discontinued,,,,CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0e3a50>,[0. 0. 0. ... 0. 0. 0.]
45,93930,CHEMBL62193,"Sulfadimethoxine (BAN, INN, JAN, MI, NF, USP); Sulfadimethoxine Sodium (USP)",4,,Hoffmann-Laroche,sulfa-,antimicrobials (sulfonamides derivatives),sulfa-,,,J01ED01,J01ED01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Long-acting sulfonamides],,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,N,N,N,N,Withdrawn,,United States; United States,,COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0e3890>,[0. 0. 0. ... 0. 0. 0.]
50,74284,CHEMBL880,"Famciclovir (BAN, FDA, INN, USAN)",4,BRL-42810,Novartis Pharmaceuticals Corp,-vir,antivirals: antivirals (acyclovir type),-vir (-ciclovir),1992.0,1994.0,S01AD07; J05AB09,S01AD07 [Sensory Organs:Ophthalmologicals:Antiinfectives:Antivirals]; J05AB09 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleosides and nucleotides excl. reverse transcriptase inhibitors],Antiviral,US-5840763-A,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,N,N,Prescription-only,,,,CC(=O)OCC(CCn1cnc2cnc(N)nc12)COC(=O)C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0e3740>,[0. 1. 0. ... 0. 0. 0.]
63,1383228,CHEMBL2110788,"Benzilonium Bromide (BAN, INN, USAN)",4,CI-379; CN-20172-3; PU-239,Parke-Davis,-ium,quaternary ammonium derivatives,-ium,1961.0,,A03AB01,"A03AB01 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Synthetic anticholinergics, quaternary ammonium compounds]",Anticholinergic,,Synthetic Small Molecule,Y,N,Racemic Mixture,N,N,N,N,N,Unknown,,,,CC[N+]1(CC)CCC(C1)OC(=O)C(O)(c2ccccc2)c3ccccc3,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0e33c0>,[0. 0. 0. ... 0. 0. 0.]
72,15371,CHEMBL277100,"Temafloxacin (BAN, INN); Temafloxacin HCl (USAN)",4,ABBOTT-62254,Abbott,-oxacin,antibacterials (quinolone derivatives),-oxacin,1988.0,1992.0,J01MA05,J01MA05 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones],Antibacterial (microbial DNA topoisomerase inhibitor),,Synthetic Small Molecule,Y,N,Racemic Mixture,N,N,N,N,N,Withdrawn,1992.0,United States; United Kingdom; Germany,"Low blood sugar; hemolytic anemia; kidney, liver dysfunction; allergic reactions",CC1CN(CCN1)c2cc3N(C=C(C(=O)O)C(=O)c3cc2F)c4ccc(F)cc4F,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0e3350>,[0. 0. 0. ... 0. 0. 0.]
91,674400,CHEMBL1200449,"Triamcinolone Diacetate (FDA, JAN, USP)",4,,Sandoz Canada Inc; Bristol Myers Squibb Co; Astellas Pharma Us Inc,-olone,steroids (not prednisolone derivatives),-olone,,1959.0,D07XB02; R01AD11; A01AC01; S01BA05; C05AA12; R03BA06; H02AB08; D07AB09,"D07XB02 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, moderately potent, other combinations]; R01AD11 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Corticosteroids]; A01AC01 [Alimentary Tract And Metabolism:Stomatological Preparations:Stomatological Preparations:Corticosteroids for local oral treatment]; S01BA05 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; C05AA12 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; R03BA06 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Drugs For Obstructive Airway Diseases, Inhalants:Glucocorticoids]; H02AB08 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; D07AB09 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, moderately potent (group II)]",Glucocorticoid,,Natural Product-derived,Y,N,Single Stereoisomer,Y,Y,Y,N,N,Discontinued,,,,CC(=O)OCC(=O)[C@@]1(O)[C@@H](C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)OC(=O)C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0e3200>,[0. 0. 0. ... 0. 0. 1.]
98,241,CHEMBL8,"Ciprofloxacin (BAN, FDA, INN, USAN, USP); Ciprofloxacin HCl (FDA, JAN, USAN, USP)",4,BAY-Q-3939; BAY-O-9867 Monohydrate; BAY-O-9867,Depomed Inc; Bayer Pharmaceuticals Corp; Bayer Healthcare Pharmaceuticals Inc; Alcon Pharmaceuticals Ltd; Wraser Pharmaceuticals Llc,-oxacin,antibacterials (quinolone derivatives),-oxacin,1987.0,1987.0,S01AE03; J01MA02; S03AA07; S02AA15,S01AE03 [Sensory Organs:Ophthalmologicals:Antiinfectives:Fluoroquinolones]; J01MA02 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones]; S03AA07 [Sensory Organs:Ophthalmological And Otological Preparations:Antiinfectives:Antiinfectives]; S02AA15 [Sensory Organs:Otologicals:Antiinfectives:Antiinfectives],Antibacterial,US-5972389-A,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,Y,Y,Y,Prescription-only,,,,OC(=O)C1=CN(C2CC2)c3cc(N4CCNCC4)c(F)cc3C1=O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0e3120>,[0. 0. 0. ... 0. 0. 0.]
101,602271,CHEMBL601719,"Crizotinib (FDA, INN, USAN)",4,PF-2341066,Pfizer Inc.,-tinib,tyrosine kinase inhibitors,-tinib,2009.0,2011.0,L01XE16,L01XE16 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors],,US-7230098-B2,Synthetic Small Molecule,Y,Y,Single Stereoisomer,N,Y,N,N,N,Prescription-only,,,,C[C@@H](Oc1cc(cnc1N)c2cnn(c2)C3CCNCC3)c4c(Cl)ccc(F)c4Cl,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0e30b0>,[0. 1. 0. ... 0. 0. 0.]
112,374064,CHEMBL1443,"Nafcillin (BAN, INN); Nafcillin Sodium (FDA, USAN, USP)",4,WY-3277,Wyeth Ayerst Laboratories; Baxter Healthcare Corp,-cillin,penicillins,-cillin,1963.0,1965.0,J01CF06,"J01CF06 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Beta-lactamase resistant penicillins]",Antibacterial,,Natural Product-derived,Y,N,Single Stereoisomer,N,Y,Y,N,N,Prescription-only,,,,CCOc1ccc2ccccc2c1C(=O)N[C@H]3[C@H]4SC(C)(C)[C@@H](N4C3=O)C(=O)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0e0f20>,[0. 0. 0. ... 0. 0. 0.]
118,381691,CHEMBL1451,"Triamcinolone (BAN, FDA, INN, JAN, USP)",4,,Bristol Myers Squibb Co; Astellas Pharma Us Inc,-olone,steroids (not prednisolone derivatives),-olone,,1957.0,D07XB02; R01AD11; A01AC01; S01BA05; C05AA12; R03BA06; H02AB08; D07AB09,"D07XB02 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, moderately potent, other combinations]; R01AD11 [Respiratory System:Nasal Preparations:Decongestants And Other Nasal Preparations For Topical Use:Corticosteroids]; A01AC01 [Alimentary Tract And Metabolism:Stomatological Preparations:Stomatological Preparations:Corticosteroids for local oral treatment]; S01BA05 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; C05AA12 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; R03BA06 [Respiratory System:Drugs For Obstructive Airway Diseases:Other Drugs For Obstructive Airway Diseases, Inhalants:Glucocorticoids]; H02AB08 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; D07AB09 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, moderately potent (group II)]",Glucocorticoid,,Natural Product-derived,Y,N,Single Stereoisomer,N,Y,N,N,N,Discontinued,,,,C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0e0dd0>,[0. 0. 0. ... 0. 0. 0.]
123,56432,CHEMBL819,"Oxacillin (BAN, INN); Oxacillin sodium (FDA, JAN, USAN, USP)",4,P-12; SO 16423; SQ-16423,Baxter Healthcare Corp; Apothecon Sub Bristol Myers Squibb Co; Apothecon Inc Div Bristol Myers Squibb,-cillin,penicillins,-cillin,1962.0,1971.0,J01CF04,"J01CF04 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Beta-lactamase resistant penicillins]",Antibacterial,,Natural Product-derived,Y,N,Single Stereoisomer,N,Y,Y,N,N,Prescription-only,,,,Cc1onc(c2ccccc2)c1C(=O)N[C@H]3[C@H]4SC(C)(C)[C@@H](N4C3=O)C(=O)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0e0c80>,[0. 0. 0. ... 0. 0. 0.]
126,228121,CHEMBL1229,"Oseltamivir (BAN, INN); Oseltamivir Phosphate (FDA, USAN)",4,Ro-640796; Ro-640796002; Ro-64-0796-002,Hoffmann La Roche Inc,-vir,antivirals: neuraminidase inhibitors,-vir (-amivir),1998.0,1999.0,J05AH02,J05AH02 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Neuraminidase inhibitors],,US-5763483-A,Synthetic Small Molecule,Y,N,Single Stereoisomer,Y,Y,N,N,N,Prescription-only,,,,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(=O)C)[C@@H](N)C1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0e0c10>,[0. 1. 0. ... 0. 0. 0.]
155,32842,CHEMBL700,"Sulfapyridine (BAN, FDA, INN, USP); Sulfapyridine Sodium (MI, NF)",4,,Eli Lilly And Co,sulfa-,antimicrobials (sulfonamides derivatives),sulfa-,,1939.0,J01EB04,J01EB04 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Short-acting sulfonamides],Suppressant (dermatitis herpetiformis),,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,N,N,Discontinued,,,,Nc1ccc(cc1)S(=O)(=O)Nc2ccccn2,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0e0660>,[0. 0. 0. ... 0. 0. 0.]
243,1363818,CHEMBL2079587,"Stanozolol (BAN, FDA, INN, JAN, USAN, USP)",4,WIN-14833,Lundbeck Inc,-olol,beta-blockers (propranolol type),-olol,1962.0,1962.0,A14AA02,A14AA02 [Alimentary Tract And Metabolism:Anabolic Agents For Systemic Use:Anabolic Steroids:Androstan derivatives],Androgen,,Natural Product-derived,Y,N,Racemic Mixture,N,Y,N,N,N,Discontinued,,,,C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4Cc5n[nH]cc5C[C@]4(C)[C@H]3CC[C@]12C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0e0200>,[0. 0. 0. ... 0. 0. 0.]
262,365538,CHEMBL184,"Aciclovir (BAN, INN, JAN); Acyclovir (FDA, USAN, USP); Acyclovir sodium (FDA, USAN)",4,BW-248U Sodium,Valeant International Barbados Srl; GlaxoSmithKline,-vir,antivirals: antivirals (acyclovir type),-vir (-cyclovir),1979.0,1982.0,D06BB53; D06BB03; J05AB01; S01AD03,D06BB53 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Antivirals]; D06BB03 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Antivirals]; J05AB01 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleosides and nucleotides excl. reverse transcriptase inhibitors]; S01AD03 [Sensory Organs:Ophthalmologicals:Antiinfectives:Antivirals],Antiviral,US-6514980-B1,Natural Product-derived,Y,N,Achiral Molecule,Y,Y,Y,Y,N,Prescription-only,,,,Nc1nc(O)c2ncn(COCCO)c2n1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0e0040>,[0. 0. 0. ... 0. 0. 0.]
266,153330,CHEMBL1109,"Sulfaphenazole (BAN, FDA, INN, JAN, MI)",4,,Purdue Frederick Co; Pharmaceutical Research Assoc Inc,sulfa-,antimicrobials (sulfonamides derivatives),sulfa-,,1982.0,S01AB05; J01ED08,S01AB05 [Sensory Organs:Ophthalmologicals:Antiinfectives:Sulfonamides]; J01ED08 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Long-acting sulfonamides],,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,N,N,Discontinued,,,,Nc1ccc(cc1)S(=O)(=O)Nc2ccnn2c3ccccc3,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0daf20>,[0. 0. 0. ... 0. 0. 0.]
321,321707,CHEMBL1380,"Abacavir (BAN, INN); Abacavir Sulfate (FDA, USAN); Abacavir Succinate (USAN)",4,1592U89,Viiv Healthcare Co; Glaxo Wellcome,-vir,antivirals: carbocyclic nucleosides,-vir (-cavir),1996.0,1998.0,J05AF06,J05AF06 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleoside and nucleotide reverse transcriptase inhibitors],Antiviral,US-5905082-A,Synthetic Small Molecule,Y,N,Single Stereoisomer,Y,Y,N,N,Y,Prescription-only,,,,Nc1nc(NC2CC2)c3ncn([C@@H]4C[C@H](CO)C=C4)c3n1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0dac10>,[0. 0. 0. ... 0. 0. 0.]
322,297372,CHEMBL1349,"Valaciclovir (INN, BAN); Valacyclovir HCl (FDA, USAN)",4,256U87 HCl,GlaxoSmithKline,-vir,antivirals: antivirals (acyclovir type),-vir (-cyclovir),1993.0,1995.0,J05AB11,J05AB11 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleosides and nucleotides excl. reverse transcriptase inhibitors],Antiviral,US-5879706-A,Natural Product-derived,Y,N,Single Stereoisomer,Y,Y,N,N,N,Prescription-only,,,,CC(C)[C@H](N)C(=O)OCCOCn1cnc2C(=O)N=C(N)Nc12,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0daba0>,[0. 1. 0. ... 0. 1. 0.]
325,1370,CHEMBL27,"Propranolol (BAN, INN); Propranolol HCl (FDA, JAN, USAN, USP)",4,AY-64043; ICI-45520,Wyeth Ayerst Laboratories; GlaxoSmithKline Llc; Baxter Healthcare Corp Anesthesia Critical Care; Akrimax Pharmaceuticals Llc,-olol,beta-blockers (propranolol type),-olol,1965.0,1967.0,C07AA05,"C07AA05 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, non-selective]",Anti-Adrenergic (beta-receptor); Cardiac Depressant (anti-arrhythmic),US-6500454-B1,Synthetic Small Molecule,Y,N,Racemic Mixture,N,Y,Y,N,Y,Prescription-only,,,,CC(C)NCC(O)COc1cccc2ccccc12,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0dab30>,[0. 1. 0. ... 0. 0. 0.]
356,233553,CHEMBL139877,"Sulfacarbamide (BAN, DCF, INN)",4,,,sulfa-,antimicrobials (sulfonamides derivatives),sulfa-,,,,,,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,N,N,N,N,Withdrawn,1988.0,Germany,"Dermatologic, Hematologic and Hepatic Reactions",NC(=O)NS(=O)(=O)c1ccc(N)cc1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0da9e0>,[0. 0. 0. ... 0. 0. 0.]
365,17136,CHEMBL583,"Grepafloxacin (INN); Grepafloxacin HCl (BAN, FDA, USAN)",4,OPC-17116,Otsuka Pharmaceutical Co Ltd,-oxacin,antibacterials (quinolone derivatives),-oxacin,1995.0,1997.0,J01MA11,J01MA11 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones],Antibacterial,,Synthetic Small Molecule,Y,N,Racemic Mixture,N,Y,N,N,N,Withdrawn,1999.0,United States; United Kingdom; United States; Germany,Cardiac repolarization; QTc interval prolongation,CC1CN(CCN1)c2cc3N(C=C(C(=O)O)C(=O)c3c(C)c2F)C4CC4,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0da890>,[0. 0. 0. ... 0. 0. 0.]
370,1853,CHEMBL430,"Gemifloxacin (INN); Gemifloxacin Mesylate (FDA, USAN)",4,LB-20304a; SB-265805-S,Cornerstone Therapeutics Inc,-oxacin,antibacterials (quinolone derivatives),-oxacin,1998.0,2003.0,J01MA15,J01MA15 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones],,US-5776944-A,Synthetic Small Molecule,Y,N,Racemic Mixture,N,Y,N,N,Y,Prescription-only,,,,CO\N=C\1/CN(CC1CN)c2nc3N(C=C(C(=O)O)C(=O)c3cc2F)C4CC4,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0da6d0>,[0. 0. 0. ... 0. 0. 0.]
380,208749,CHEMBL1194,"Prilocaine (BAN, FDA, INN, USAN, USP); Prilocaine HCl (FDA, USAN, USP); Propitocaine HCl (JAN)",4,ASTRA 1512; L-67,Oak Pharmaceuticals Inc; Dentsply Pharmaceutical Inc; Astrazeneca Lp,-caine,local anesthetics,-caine,1966.0,1965.0,N01BB54; N01BB04,"N01BB54 [Nervous System:Anesthetics:Anesthetics, Local:Amides]; N01BB04 [Nervous System:Anesthetics:Anesthetics, Local:Amides]",Anesthetic (local),US-6031007-A,Synthetic Small Molecule,Y,N,Racemic Mixture,N,N,Y,Y,N,Prescription-only,,,,CCCNC(C)C(=O)Nc1ccccc1C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0da4a0>,[0. 1. 0. ... 0. 0. 0.]
465,1051118,CHEMBL1628227,"Doxepin (BAN, INN); Doxepin HCl (FDA, USAN, USP)",4,P-3693A,Somaxon Pharmaceuticals Inc; Pfizer Laboratories Div Pfizer Inc; New River Pharmaceuticals Inc; Fougera Pharmaceuticals Inc,-pin(e),tricyclic compounds,-pin(e),1964.0,1969.0,N06AA12,N06AA12 [Nervous System:Psychoanaleptics:Antidepressants:Non-selective monoamine reuptake inhibitors],Antidepressant,US-6211229-B1,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,Y,Y,Prescription-only,,,,CN(C)CCC=C1c2ccccc2COc3ccccc13,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0da430>,[0. 0. 0. ... 0. 0. 0.]
473,15086,CHEMBL108,"Carbamazepine (BAN, FDA, INN, JAN, USAN, USP)",4,G-32883,Validus Pharmaceuticals Inc; Shire Development Inc; Novartis Pharmaceuticals Corp,-pin(e),tricyclic compounds,-pin(e),1965.0,1968.0,N03AF01,N03AF01 [Nervous System:Antiepileptics:Antiepileptics:Carboxamide derivatives],Analgesic; Anticonvulsant,US-5912013-A,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,N,Y,Prescription-only,,,,NC(=O)N1c2ccccc2C=Cc3ccccc13,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0da3c0>,[0. 0. 0. ... 0. 0. 0.]
478,62182,CHEMBL839,"Carteolol (BAN, INN); Carteolol HCl (FDA, JAN, USAN, USP)",4,ABBOTT-43326; OPC-1085,Novartis Pharmaceuticals Corp; Abbvie Inc,-olol,beta-blockers (propranolol type),-olol,1976.0,1988.0,S01ED55; S01ED05; C07AA15,"S01ED55 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Beta blocking agents1)]; S01ED05 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Beta blocking agents1)]; C07AA15 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, non-selective]",Anti-Adrenergic (beta-receptor),,Synthetic Small Molecule,Y,N,Racemic Mixture,N,Y,N,Y,N,Prescription-only,,,,CC(C)(C)NCC(O)COc1cccc2NC(=O)CCc12,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0da350>,[0. 1. 0. ... 0. 0. 0.]
518,33060,CHEMBL703,"Succinylcholine chloride (FDA, USP); Suxamethonium Chloride (BAN, DCF, INN, JAN); Suxamethonium Bromide (BAN)",4,,Sandoz Canada Inc; Hospira Inc; Apothecon Inc Div Bristol Myers Squibb,-ium,quaternary ammonium derivatives,-ium,,1952.0,M03AB01,"M03AB01 [Musculo-Skeletal System:Muscle Relaxants:Muscle Relaxants, Peripherally Acting Agents:Choline derivatives]",Neuromuscular Blocking Agent,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,N,Y,N,Y,Prescription-only,,,,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0da200>,[0. 0. 0. ... 0. 0. 0.]
523,1248741,CHEMBL1908370,"Finafloxacin (FDA, INN)",4,,Alcon Research Ltd,-oxacin,antibacterials (quinolone derivatives),-oxacin,,2014.0,,,,US-6133260-A,Synthetic Small Molecule,Y,N,Single Stereoisomer,N,N,N,Y,N,Prescription-only,,,,OC(=O)C1=CN(C2CC2)c3c(C#N)c(N4C[C@@H]5NCCO[C@H]5C4)c(F)cc3C1=O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0da190>,[0. 0. 0. ... 0. 0. 0.]
590,214701,CHEMBL1208,"Cinoxacin (BAN, FDA, INN, JAN, USAN, USP)",4,64716,Eli Lilly And Co,-oxacin,antibacterials (quinolone derivatives),-oxacin,1974.0,1980.0,J01MB06,J01MB06 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Other quinolones],Antibacterial,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,N,N,Discontinued,,,,CCN1N=C(C(=O)O)C(=O)c2cc3OCOc3cc12,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0da120>,[0. 0. 0. ... 0. 0. 0.]
625,13048,CHEMBL535,Sunitinib (INN); Sunitinib Malate (FDA),4,SU-11248,Cp Pharmaceuticals International Cv,-tinib,tyrosine kinase inhibitors,-tinib,,2006.0,L01XE04,L01XE04 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors],,US-6573293-B2,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,N,Y,Prescription-only,,,,CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C\2/C(=O)Nc3ccc(F)cc23)c1C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0d6cf0>,[0. 0. 0. ... 0. 0. 0.]
657,2131,CHEMBL439,"Sulfadiazine (BAN, FDA, INN, JAN, USP); Sulfadiazine (Trisulfapyrimidines) (FDA); Silver Sulfadiazine (FDA); Sulfadiazine Silver (JAN); Sulfadiazine, Silver (USAN, USP); Sulfadiazine Sodium (FDA, INN, USP)",4,,Eli Lilly And Co; Dr Reddys Laboratories Louisiana Llc; Bristol Myers Squibb Co; Abbvie Inc; King Pharmaceuticals Inc,sulfa-,antimicrobials (sulfonamides derivatives),sulfa-,1975.0,1941.0,J01EC02; D06BA01; D06BA51,J01EC02 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Intermediate-acting sulfonamides]; D06BA01 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Sulfonamides]; D06BA51 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Sulfonamides],"Anti-Infective, Topical; Antibacterial",,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,Y,Y,N,Prescription-only,,,,Nc1ccc(cc1)S(=O)(=O)Nc2ncccn2,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0d6ac0>,[0. 0. 0. ... 0. 0. 0.]
767,454373,CHEMBL1596,"Carindacillin (INN, BAN); Carbenicillin Indanyl Sodium (FDA, USAN, USP); Carindacillin Sodium (JAN)",4,CP-154642; CP-15464-2,Pfizer Laboratories Div Pfizer Inc,-cillin,penicillins,-cillin,1972.0,1972.0,J01CA05,"J01CA05 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Penicillins with extended spectrum]",Antibacterial,,Natural Product-derived,Y,N,Racemic Mixture,Y,Y,N,N,N,Discontinued,,,,CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)Oc3ccc4CCCc4c3)c5ccccc5)C(=O)N2[C@H]1C(=O)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0d6890>,[0. 1. 0. ... 0. 0. 0.]
785,675007,CHEMBL1201056,"Sulfacitine (INN); Sulfacytine (BAN, FDA, USAN)",4,CI-636,Glenwood Inc,sulfa-,antimicrobials (sulfonamides derivatives),sulfa-,1972.0,1975.0,,,Antibacterial,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,N,N,Discontinued,,,,CCN1C=CC(=NC1=O)NS(=O)(=O)c2ccc(N)cc2,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0d6740>,[0. 0. 0. ... 1. 0. 0.]
901,13756,CHEMBL546,"Oxprenolol (BAN, INN); Oxprenolol HCl (FDA, JAN, USAN, USP)",4,BA-39089,Novartis Pharmaceuticals Corp,-olol,beta-blockers (propranolol type),-olol,1968.0,1983.0,C07AA02,"C07AA02 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, non-selective]",Vasodilator (coronary),,Synthetic Small Molecule,Y,N,Racemic Mixture,N,Y,N,N,N,Discontinued,,,,CC(C)NCC(O)COc1ccccc1OCC=C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0d6120>,[0. 1. 0. ... 0. 0. 0.]
1041,419622,CHEMBL1504,"Triamcinolone Acetonide (BAN, FDA, JAN, USP)",4,,Apothecon Inc Div Bristol Myers Squibb; Allergan Inc; Alcon Inc; Abbvie Inc; Bristol Myers Squibb Co Pharmaceutical Research Institute,-olone,steroids (not prednisolone derivatives),-olone,,1960.0,,,Glucocorticoid,US-5976573-A,Natural Product-derived,Y,N,Single Stereoisomer,N,N,Y,Y,Y,Over-The-Counter,,,,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0d1dd0>,[0. 0. 0. ... 0. 0. 0.]
1066,43354,CHEMBL768,"Esmolol (BAN, INN); Esmolol HCl (FDA, USAN)",4,ASL-8052,Baxter Healthcare Corp,-olol,beta-blockers (propranolol type),-olol,1983.0,1986.0,C07AB09,"C07AB09 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, selective]",Anti-Adrenergic (beta-receptor),US-6310094-B1,Synthetic Small Molecule,Y,N,Racemic Mixture,N,N,Y,N,Y,Prescription-only,2007.0,United States,"Increased risk of medication errors resulting in serious adverse events, including deaths",COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0d1c10>,[0. 1. 0. ... 0. 0. 0.]
1150,218758,CHEMBL1214,"Carbenicillin (BAN, INN); Carbenicillin Disodium (FDA, USAN, USP); Carbenicillin Sodium (JAN); Carbenicillin Potassium (USAN)",4,BRL-2064; CP-15-639-2; GS-3159,Roerig Div Pfizer Inc; GlaxoSmithKline,-cillin,penicillins,-cillin,1968.0,1982.0,J01CA03,"J01CA03 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Penicillins with extended spectrum]",Antibacterial,,Natural Product-derived,Y,N,Racemic Mixture,N,N,Y,N,N,Discontinued,,,,CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)O)c3ccccc3)C(=O)N2[C@H]1C(=O)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0d16d0>,[0. 1. 0. ... 0. 0. 0.]
1192,143284,CHEMBL1082,"Amoxicillin (BAN, FDA, INN, JAN, USAN, USP); Amoxicilline (INN); Amoxicillin Sodium (USAN)",4,BRL-2333; BRL-2333AB-B,Shionogi Inc; GlaxoSmithKline; Gastroentero Logic Llc; Dr Reddys Laboratories Inc; Takeda Pharmaceuticals Usa Inc,-cillin,penicillins,-cillin,1972.0,1974.0,J01CA04,"J01CA04 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Penicillins with extended spectrum]",Antibacterial,US-6544555-B2,Natural Product-derived,Y,N,Single Stereoisomer,N,Y,N,N,N,Prescription-only,,,,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0d1510>,[0. 1. 0. ... 0. 0. 0.]
1204,8543,CHEMBL500,"Pindolol (BAN, FDA, INN, JAN, USAN, USP)",4,LB-46,Novartis Pharmaceuticals Corp,-olol,beta-blockers (propranolol type),-olol,1970.0,1982.0,C07AA03,"C07AA03 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, non-selective]",Vasodilator,,Synthetic Small Molecule,Y,N,Racemic Mixture,N,Y,N,N,N,Prescription-only,,,,CC(C)NCC(O)COc1cccc2[nH]ccc12,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0d1430>,[0. 1. 1. ... 0. 0. 0.]
1205,674536,CHEMBL1200585,"Oxymetholone (BAN, FDA, INN, JAN, USAN, USP)",4,CI-406,Meda Pharmaceuticals Inc,-olone,steroids (not prednisolone derivatives),-olone,1963.0,1972.0,A14AA05,A14AA05 [Alimentary Tract And Metabolism:Anabolic Agents For Systemic Use:Anabolic Steroids:Androstan derivatives],Androgen,,Natural Product-derived,Y,N,Single Stereoisomer,N,Y,N,N,Y,Prescription-only,,,,C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)\C(=C/O)\C[C@]4(C)[C@H]3CC[C@]12C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0d13c0>,[0. 0. 0. ... 0. 0. 0.]
1249,675144,CHEMBL1201193,"Levobupivacaine (BAN, INN); Levobupivacaine HCl (FDA, USAN)",4,,Purdue Pharma Lp,-caine,local anesthetics,-caine,1998.0,1999.0,N01BB10,"N01BB10 [Nervous System:Anesthetics:Anesthetics, Local:Amides]",,,Synthetic Small Molecule,Y,N,Single Stereoisomer,N,N,Y,N,N,Discontinued,,,,CCCCN1CCCC[C@H]1C(=O)Nc2c(C)cccc2C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0d12e0>,[0. 0. 0. ... 0. 0. 0.]
1469,1817518,CHEMBL3353410,"Osimertinib (USAN); Osimertinib mesylate (FDA, USAN)",4,AZD-9291; AZD-9291 mesylate,Astrazeneca Pharmaceuticals Lp; Astrazeneca,-tinib,tyrosine kinase inhibitors,-tinib,2015.0,2015.0,,,,US-8946235-B2,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,N,N,Prescription-only,,,,COc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc2nccc(n2)c3cn(C)c4ccccc34,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0cde40>,[0. 0. 0. ... 0. 0. 0.]
1484,76766,CHEMBL891,"Cloxacillin (BAN, INN); Cloxacillin Sodium (FDA, JAN, USAN, USP); Cloxacillin Benzathine (USP)",4,BRL-1621; P-25,Apothecon Inc Div Bristol Myers Squibb,-cillin,penicillins,-cillin,1963.0,1974.0,J01CF02,"J01CF02 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Beta-lactamase resistant penicillins]",Antibacterial,,Natural Product-derived,Y,N,Single Stereoisomer,N,Y,N,N,N,Discontinued,,,,Cc1onc(c2ccccc2Cl)c1C(=O)N[C@H]3[C@H]4SC(C)(C)[C@@H](N4C3=O)C(=O)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0cdd60>,[0. 0. 0. ... 0. 0. 0.]
1645,675188,CHEMBL1201237,"Levobunolol (BAN, INN); Levobunolol HCl (FDA, USAN, USP)",4,W-7000A,Allergan Pharmaceutical,-olol,beta-blockers (propranolol type),-olol,1979.0,1985.0,S01ED03,S01ED03 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Beta blocking agents1)],Anti-Adrenergic (beta-receptor),,Synthetic Small Molecule,Y,N,Single Stereoisomer,N,N,N,Y,N,Prescription-only,,,,CC(C)(C)NC[C@H](O)COc1cccc2C(=O)CCCc12,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0cd820>,[0. 1. 1. ... 0. 0. 0.]
1697,1626743,CHEMBL3137312,"Dasabuvir (INN, USAN); Dasabuvir sodium (FDA)",4,ABT-333,Abbvie Inc.; Abbvie Inc,-vir,antivirals: RNA polymerase (NS5B) inhibitor,-vir (-buvir),2013.0,2014.0,J05AX16,J05AX16 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Other antivirals],,US-6037157-A,Natural Product-derived,Y,N,Achiral Molecule,N,Y,N,N,N,Prescription-only,,,,COc1c(cc(cc1C(C)(C)C)N2C=CC(=O)NC2=O)c3ccc4cc(NS(=O)(=O)C)ccc4c3,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0cd740>,[0. 0. 0. ... 0. 0. 0.]
1731,675711,CHEMBL1201760,"Besifloxacin (INN); Besifloxacin HCl (FDA, USAN)",4,BOL-303224-A; SS-734,Bausch And Lomb Inc,-oxacin,antibacterials (quinolone derivatives),-oxacin,2007.0,2009.0,S01AE08,S01AE08 [Sensory Organs:Ophthalmologicals:Antiinfectives:Fluoroquinolones],,US-5447926-A,Synthetic Small Molecule,Y,N,Single Stereoisomer,N,N,N,Y,N,Prescription-only,,,,N[C@@H]1CCCCN(C1)c2c(F)cc3C(=O)C(=CN(C4CC4)c3c2Cl)C(=O)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0cd5f0>,[1. 0. 0. ... 0. 0. 0.]
1879,8531,CHEMBL499,"Timolol (BAN, FDA, INN, USAN); Timolol Maleate (FDA, JAN, USAN, USP)",4,,Ista Pharmaceuticals; Falcon Pharmaceuticals Ltd; Aton Pharma Inc; Allergan Inc; Santen Oy,-olol,beta-blockers (propranolol type),-olol,1973.0,1978.0,C07AA06; S01ED51; S01ED01,"C07AA06 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, non-selective]; S01ED51 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Beta blocking agents1)]; S01ED01 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Beta blocking agents1)]",Anti-Adrenergic (beta-receptor),US-6174524-B1,Synthetic Small Molecule,Y,N,Single Stereoisomer,N,Y,N,Y,Y,Prescription-only,,,,CC(C)(C)NC[C@H](O)COc1nsnc1N2CCOCC2,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0cd190>,[0. 1. 0. ... 0. 0. 0.]
1892,716337,CHEMBL1289926,"Axitinib (FDA, INN, USAN)",4,AG-013736; AG-13736,Pfizer Inc.,-tinib,tyrosine kinase inhibitors,-tinib,2005.0,2012.0,L01XE17,L01XE17 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors],,US-6534524-B1,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,N,N,Prescription-only,,,,CNC(=O)c1ccccc1Sc2ccc3c(\C=C\c4ccccn4)n[nH]c3c2,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0c6e40>,[0. 1. 0. ... 0. 0. 0.]
2032,1676656,CHEMBL3187365,"Asenapine (INN); Asenapine maleate (FDA, USAN)",4,ORG-5222,Organon Usa Inc Sub Merck And Co Inc,-pin(e),tricyclic compounds,-pin(e),2002.0,2009.0,N05AH05,"N05AH05 [Nervous System:Psycholeptics:Antipsychotics:Diazepines, oxazepines, thiazepines and oxepines]",,US-5763476-A,Synthetic Small Molecule,Y,N,Racemic Mixture,N,N,N,Y,Y,Prescription-only,,,,CN1CC2C(C1)c3cc(Cl)ccc3Oc4ccccc24,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0c69e0>,[0. 0. 1. ... 0. 0. 0.]
2108,430546,CHEMBL1539,"Sulfadoxine (BAN, FDA, INN, JAN, USAN, USP)",4,Ro-44393,Hoffmann La Roche Inc,sulfa-,antimicrobials (sulfonamides derivatives),sulfa-,1968.0,1981.0,,,Antibacterial,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,N,N,Discontinued,,,,COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0c66d0>,[0. 0. 0. ... 0. 0. 0.]
2119,88797,CHEMBL941,"Imatinib (BAN, INN); Imatinib mesylate (FDA)",4,STI-571,Novartis Pharmaceuticals Corp,-tinib,tyrosine kinase inhibitors,-tinib,,2001.0,L01XE01,L01XE01 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors],,US-5521184-A,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,N,N,Prescription-only,,,,CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)CC1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0c64a0>,[0. 0. 0. ... 0. 0. 0.]
2225,27347,CHEMBL642,"Acebutolol (BAN, INN, USAN); Acebutolol HCl (FDA, JAN, USP)",4,IL-17803A; M&B-17803A,Promius Pharma Llc,-olol,beta-blockers (propranolol type),-olol,1973.0,1984.0,C07AB04,"C07AB04 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, selective]",Anti-Adrenergic (beta-receptor),,Synthetic Small Molecule,Y,N,Racemic Mixture,N,Y,N,N,N,Prescription-only,,,,CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(c1)C(=O)C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0c6270>,[0. 1. 0. ... 0. 0. 0.]
2227,16581,CHEMBL569,"Procaine (BAN, INN); Procaine HCl (FDA, JAN, USP)",4,,Lederle Laboratories Div American Cyanamid Co; Eastman Kodak Co,-caine,local anesthetics,-caine,,1954.0,N01BA02; C05AD05; N01BA52; S01HA05,"N01BA02 [Nervous System:Anesthetics:Anesthetics, Local:Esters of aminobenzoic acid]; C05AD05 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Local anesthetics]; N01BA52 [Nervous System:Anesthetics:Anesthetics, Local:Esters of aminobenzoic acid]; S01HA05 [Sensory Organs:Ophthalmologicals:Local Anesthetics:Local anesthetics]",Anesthetic (local),,Synthetic Small Molecule,Y,N,Achiral Molecule,N,N,Y,N,N,Discontinued,,,,CCN(CC)CCOC(=O)c1ccc(N)cc1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0c6190>,[0. 0. 0. ... 0. 0. 0.]
2247,618203,CHEMBL1077896,"Ropivacaine (BAN, INN); Ropivacaine HCl (FDA, USP)",4,,Fresenius Kabi Usa Llc; Astra,-caine,local anesthetics,-caine,,1996.0,N01BB09,"N01BB09 [Nervous System:Anesthetics:Anesthetics, Local:Amides]",,US-7828787-B2,Synthetic Small Molecule,Y,N,Single Stereoisomer,N,N,Y,N,N,Prescription-only,,,,CCCN1CCCC[C@H]1C(=O)Nc2c(C)cccc2C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc0c60b0>,[0. 0. 0. ... 0. 0. 0.]
2320,2525,CHEMBL455,"Sulfacetamide (BAN, INN, USP); Sulfacetamide (Triple Sulfa) (FDA); Sulfacetamide sodium (FDA, USP)",4,,Sanofi Aventis Us Llc; Ortho Mcneil Pharmaceutical Inc; Novartis Pharmaceuticals Corp; Allergan Pharmaceutical; Schering Corp Sub Schering Plough Corp,sulfa-,antimicrobials (sulfonamides derivatives),sulfa-,,1945.0,S01AB04; D10AF06,S01AB04 [Sensory Organs:Ophthalmologicals:Antiinfectives:Sulfonamides]; D10AF06 [Dermatologicals:Anti-Acne Preparations:Anti-Acne Preparations For Topical Use:Antiinfectives for treatment of acne],Antibacterial,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,N,N,Y,N,Prescription-only,,,,CC(=O)NS(=O)(=O)c1ccc(N)cc1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc141c80>,[0. 0. 0. ... 0. 0. 0.]
2410,1152068,CHEMBL1788404,Bephenium,4,,,-ium,quaternary ammonium derivatives,-ium,,,P02CX02,"P02CX02 [Antiparasitic Products, Insecticides And Repellents:Anthelmintics:Antinematodal Agents:Other antinematodals]",,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,N,N,N,N,Unknown,,,,C[N+](C)(CCOc1ccccc1)Cc2ccccc2,<rdkit.Chem.rdchem.Mol object at 0x7f91dc141b30>,[0. 0. 0. ... 0. 0. 0.]
2616,2261,CHEMBL42,"Clozapine (BAN, FDA, INN, USAN, USP)",4,HF-1854,Novartis Pharmaceuticals Corp; Jazz Pharmaceuticals Iii International Ltd,-pin(e),tricyclic compounds,-pin(e),1969.0,1989.0,N05AH02,"N05AH02 [Nervous System:Psycholeptics:Antipsychotics:Diazepines, oxazepines, thiazepines and oxepines]",Antipsychotic,US-6024981-A,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,N,Y,Prescription-only,,,,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,<rdkit.Chem.rdchem.Mol object at 0x7f91dc141890>,[0. 0. 0. ... 0. 0. 0.]
2861,233590,CHEMBL1243,"Sulfabenzamide (BAN, INN, USAN, USP); Sulfabenzamide (Triple Sulfa) (FDA)",4,,Ortho Mcneil Pharmaceutical Inc,sulfa-,antimicrobials (sulfonamides derivatives),sulfa-,1971.0,1945.0,,,Antibacterial,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,N,N,Y,N,Discontinued,,,,Nc1ccc(cc1)S(=O)(=O)NC(=O)c2ccccc2,<rdkit.Chem.rdchem.Mol object at 0x7f91dc1413c0>,[0. 0. 0. ... 0. 0. 0.]
2883,2247,CHEMBL443,"Acetylsulfamethoxazole (JAN); Sulfamethoxazole (BAN, FDA, INN, JAN, USAN, USP); Sulfamethoxazole Sodium (JAN)",4,Ro-42130,Monarch Pharmaceuticals Inc; Hoffmann La Roche Inc; Heather Drug Co Inc; Able Laboratories Inc; Mutual Pharmaceutical Co Inc,sulfa-,antimicrobials (sulfonamides derivatives),sulfa-,1962.0,1973.0,J01EC01,J01EC01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Intermediate-acting sulfonamides],Antibacterial,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,Y,N,N,Prescription-only,,,,Cc1onc(NS(=O)(=O)c2ccc(N)cc2)c1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc141270>,[0. 0. 0. ... 0. 0. 0.]
2942,675237,CHEMBL1201286,"Oxyphenonium Bromide (BAN, FDA, INN, MI)",4,,Novartis Pharmaceuticals Corp,-ium,quaternary ammonium derivatives,-ium,,1982.0,A03AB53; A03AB03,"A03AB53 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Synthetic anticholinergics, quaternary ammonium compounds]; A03AB03 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Synthetic anticholinergics, quaternary ammonium compounds]",,,Synthetic Small Molecule,Y,N,Racemic Mixture,N,Y,N,N,N,Discontinued,,,,CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCCC1)c2ccccc2,<rdkit.Chem.rdchem.Mol object at 0x7f91dc141190>,[0. 0. 1. ... 0. 0. 0.]
2959,2516,CHEMBL268869,"Sulfamethoxypyridazine (BAN, INN, MI, USP)",4,,Parke-Davis,sulfa-,antimicrobials (sulfonamides derivatives),sulfa-,,,J01ED05,J01ED05 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Long-acting sulfonamides],,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,N,N,N,N,Withdrawn,1986.0,United Kingdom,,COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc141040>,[0. 0. 0. ... 0. 0. 0.]
3008,674568,CHEMBL1200617,"Rimexolone (BAN, FDA, INN, USAN, USP)",4,ORG-6216,Alcon Laboratories Inc,-olone,steroids (not prednisolone derivatives),-olone,1990.0,1994.0,H02AB12; S01BA13,"H02AB12 [Systemic Hormonal Preparations, Excl. :Corticosteroids For Systemic Use:Corticosteroids For Systemic Use, Plain:Glucocorticoids]; S01BA13 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]",Anti-Inflammatory,,Natural Product-derived,Y,N,Single Stereoisomer,N,N,N,Y,N,Prescription-only,,,,CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc13cf90>,[0. 0. 0. ... 0. 1. 0.]
3177,2265,CHEMBL446,"Sulfadimidine (BAN, INN); Sulfamethazine (USP); Sulfamethazine (Trisulfapyrimidines) (FDA)",4,,Lederle Laboratories Div American Cyanamid Co; Eli Lilly And Co; Bristol Myers Squibb Co,sulfa-,antimicrobials (sulfonamides derivatives),sulfa-,,1949.0,J01EB03,J01EB03 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Short-acting sulfonamides],Antibacterial,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,N,N,Discontinued,,,,Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc13cba0>,[0. 0. 0. ... 0. 0. 0.]
3231,674551,CHEMBL1200600,"Fluorometholone (BAN, FDA, INN, JAN, USP)",4,,Pharmacia And Upjohn Co; Allergan Pharmaceutical,-olone,steroids (not prednisolone derivatives),-olone,,1972.0,D10AA01; S01CB05; C05AA06; S01BA07; D07XB04; D07AB06,"D10AA01 [Dermatologicals:Anti-Acne Preparations:Anti-Acne Preparations For Topical Use:Corticosteroids, combinations for treatment of acne]; S01CB05 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents And Antiinfectives In Combination:Corticosteroids/antiinfectives/mydriatics in combination]; C05AA06 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]; S01BA07 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; D07XB04 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Other Combinations:Corticosteroids, moderately potent, other combinations]; D07AB06 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, moderately potent (group II)]",Glucocorticoid,,Natural Product-derived,Y,N,Single Stereoisomer,N,N,N,Y,N,Prescription-only,,,,C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)C)[C@@]3(C)C[C@H](O)[C@]2(F)[C@@]4(C)C=CC(=O)C=C14,<rdkit.Chem.rdchem.Mol object at 0x7f91dc13ca50>,[0. 0. 0. ... 0. 0. 0.]
3233,48701,CHEMBL152,"Cidofovir (BAN, FDA, INN, USAN)",4,GS-0504,Gilead Sciences Inc,-vir,antivirals,-vir,1994.0,1996.0,J05AB12,J05AB12 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleosides and nucleotides excl. reverse transcriptase inhibitors],Antiviral,,Natural Product-derived,Y,N,Single Stereoisomer,N,N,Y,N,Y,Prescription-only,,,,NC1=NC(=O)N(C[C@@H](CO)OCP(=O)(O)O)C=C1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc13c970>,[0. 1. 0. ... 0. 0. 0.]
3295,674310,CHEMBL1200359,"Sulfameter (FDA, USAN); Sulfametoxydiazine (BAN, DCF, INN)",4,AHR-857,Bayer Healthcare Pharmaceuticals Inc,sulfa-,antimicrobials (sulfonamides derivatives),sulfa-,1967.0,1966.0,J01ED04,J01ED04 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Long-acting sulfonamides],Antibacterial,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,N,N,Withdrawn,1988.0,Germany,,COc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc13c660>,[0. 0. 0. ... 0. 0. 0.]
3326,1712,CHEMBL31,"Gatifloxacin (FDA, INN, USAN)",4,AM-1155; BMS-206584-01,Allergan Inc; Allergan,-oxacin,antibacterials (quinolone derivatives),-oxacin,1997.0,1999.0,J01MA16; S01AE06,J01MA16 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones]; S01AE06 [Sensory Organs:Ophthalmologicals:Antiinfectives:Fluoroquinolones],Antibacterial,US-5880283-A,Synthetic Small Molecule,Y,N,Racemic Mixture,N,Y,Y,Y,N,Prescription-only,2006.0,United States,Increased risk of dysglycemia,COc1c(N2CCNC(C)C2)c(F)cc3C(=O)C(=CN(C4CC4)c13)C(=O)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc13c040>,[0. 0. 0. ... 0. 0. 0.]
3377,209007,CHEMBL1196,"Proxymetacaine (INN, BAN, DCF); Proparacaine HCl (FDA, USP)",4,,Apothecon Inc Div Bristol Myers Squibb; Allergan Pharmaceutical,-caine,local anesthetics,-caine,,1953.0,S01HA04,S01HA04 [Sensory Organs:Ophthalmologicals:Local Anesthetics:Local anesthetics],"Anesthetic (topical, ophthalmic)",,Synthetic Small Molecule,Y,N,Achiral Molecule,N,N,N,Y,N,Prescription-only,,,,CCCOc1ccc(cc1N)C(=O)OCCN(CC)CC,<rdkit.Chem.rdchem.Mol object at 0x7f91dc12fc80>,[0. 0. 0. ... 0. 0. 0.]
3460,2130,CHEMBL438,"Sulfamerazine (BAN, FDA, INN, USP); Sulfamerazine (Trisulfapyrimidines) (FDA); Sulfamerazine Sodium [Injection] (INN, NF)",4,,Lederle Laboratories Div American Cyanamid Co; Eli Lilly And Co; Bristol Myers Squibb Co,sulfa-,antimicrobials (sulfonamides derivatives),sulfa-,,1982.0,J01ED07; D06BA06,J01ED07 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Long-acting sulfonamides]; D06BA06 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Sulfonamides],Antibacterial,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,N,N,Discontinued,,,,Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc12f890>,[0. 0. 0. ... 0. 0. 0.]
3464,674926,CHEMBL1200975,"Clocortolone Pivalate (FDA, USAN, USP)",4,SH-863,Promius Pharma Llc,-olone,steroids (not prednisolone derivatives),-olone,1972.0,1977.0,D07AB21,"D07AB21 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, moderately potent (group II)]",Glucocorticoid,,Natural Product-derived,Y,N,Single Stereoisomer,N,N,N,Y,N,Prescription-only,,,,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc12f7b0>,[0. 0. 0. ... 0. 0. 0.]
3614,65351,CHEMBL850,"Sparfloxacin (BAN, FDA, INN, JAN, USAN)",4,AT-4140; CI-978,Mylan Pharmaceuticals Inc,-oxacin,antibacterials (quinolone derivatives),-oxacin,1991.0,1996.0,J01MA09,J01MA09 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones],Antibacterial,,Synthetic Small Molecule,Y,N,Single Stereoisomer,N,Y,N,N,N,Withdrawn,2001.0,United States,QT prolongation and phototoxicity,C[C@@H]1CN(C[C@H](C)N1)c2c(F)c(N)c3C(=O)C(=CN(C4CC4)c3c2F)C(=O)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc12f580>,[0. 0. 0. ... 0. 0. 0.]
3699,150882,CHEMBL1098,"Bupivacaine (BAN, FDA, INN, USAN); Bupivacaine HCl (FDA, JAN, USAN, USP)",4,SKY-0402; LAC-43; WIN-11318,Pacira Pharmaceuticals Inc; Hospira Inc; Fresenius Kabi Usa Llc; Amphastar Pharmaceuticals Inc,-caine,local anesthetics,-caine,1967.0,1972.0,N01BB01; N01BB51,"N01BB01 [Nervous System:Anesthetics:Anesthetics, Local:Amides]; N01BB51 [Nervous System:Anesthetics:Anesthetics, Local:Amides]",Anesthetic (local),US-8182835-B2,Synthetic Small Molecule,Y,N,Racemic Mixture,N,N,Y,N,Y,Prescription-only,,,,CCCCN1CCCCC1C(=O)Nc2c(C)cccc2C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc12f510>,[0. 0. 0. ... 0. 0. 0.]
3765,1153572,CHEMBL1789941,"Ruxolitinib (INN, USAN); Ruxolitinib Phosphate (FDA, USAN)",4,INCB-018424; INCB-018424 Salt,Incyte Corp,-tinib,tyrosine kinase inhibitors,-tinib,2009.0,2011.0,L01XE18,L01XE18 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors],,US-7598257-B2,Synthetic Small Molecule,Y,Y,Single Stereoisomer,N,Y,N,N,N,Prescription-only,,,,N#CC[C@H](C1CCCC1)n2cc(cn2)c3ncnc4[nH]ccc34,<rdkit.Chem.rdchem.Mol object at 0x7f91dc12f3c0>,[0. 1. 1. ... 0. 0. 0.]
3838,674387,CHEMBL1200436,"Oxandrolone (BAN, FDA, INN, JAN, USAN, USP)",4,SC-11585,Savient Pharmaceuticals Inc,-olone,steroids (not prednisolone derivatives),-olone,1962.0,1964.0,A14AA08,A14AA08 [Alimentary Tract And Metabolism:Anabolic Agents For Systemic Use:Anabolic Steroids:Androstan derivatives],Androgen,US-5872147-A,Natural Product-derived,Y,N,Single Stereoisomer,N,Y,N,N,Y,Prescription-only,,,,C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)OC[C@]4(C)[C@H]3CC[C@]12C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc12f200>,[0. 0. 0. ... 0. 0. 0.]
3979,430597,CHEMBL1540,"Penciclovir (BAN, INN, USAN); Penciclovir sodium (FDA, USAN)",4,BRL-39123; BRL-39123-D,SmithKline Beecham; Denco Asset Llc,-vir,antivirals: antivirals (acyclovir type),-vir (-ciclovir),1992.0,1996.0,J05AB13; D06BB06,J05AB13 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleosides and nucleotides excl. reverse transcriptase inhibitors]; D06BB06 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Antivirals],Antiviral,US-5840763-A,Natural Product-derived,Y,N,Achiral Molecule,N,N,N,Y,N,Prescription-only,,,,Nc1nc(O)c2ncn(CCC(CO)CO)c2n1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc12aac0>,[0. 1. 0. ... 0. 0. 0.]
4051,88232,CHEMBL939,"Gefitinib (BAN, FDA, INN, USAN)",4,ZD-1839,Astrazeneca Uk Ltd,-tinib,tyrosine kinase inhibitors,-tinib,2002.0,2003.0,L01XE02,L01XE02 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors],,US-5770599-A,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,N,N,Prescription-only,,,,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN4CCOCC4,<rdkit.Chem.rdchem.Mol object at 0x7f91dc12a970>,[0. 0. 0. ... 0. 0. 0.]
4055,203048,CHEMBL1190,"Decamethonium Bromide (FDA, INN, MI, USP); Decamethonium Iodide (BAN)",4,,GlaxoSmithKline,-ium,quaternary ammonium derivatives,-ium,,1982.0,,,,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,N,Y,N,N,Discontinued,,,,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc12a890>,[0. 0. 0. ... 0. 0. 0.]
4127,1616,CHEMBL428,"Trovafloxacin (INN); Trovafloxacin Mesylate (FDA, USAN)",4,CP-9921927; CP-99219-27,Pfizer Pharmaceuticals Inc; Pfizer Central Research,-oxacin,antibacterials (quinolone derivatives),-oxacin,1995.0,1997.0,J01MA13,J01MA13 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones],Antibacterial,,Synthetic Small Molecule,Y,N,Single Stereoisomer,N,Y,N,N,Y,Withdrawn,1999.0,European Union; United States,Hepatotoxicity,N[C@@H]1[C@H]2CN(C[C@@H]12)c3nc4N(C=C(C(=O)O)C(=O)c4cc3F)c5ccc(F)cc5F,<rdkit.Chem.rdchem.Mol object at 0x7f91dc12a6d0>,[0. 0. 0. ... 0. 0. 0.]
4330,693112,CHEMBL1230762,Aluminium Acetoacetate,4,,,-ium,quaternary ammonium derivatives,-ium,,,A02AB05,A02AB05 [Alimentary Tract And Metabolism:Drugs For Acid Related Disorders:Antacids:Aluminium compounds],,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,N,N,N,N,Unknown,,,,CC(=O)CC(=O)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc12a0b0>,[0. 0. 0. ... 0. 0. 0.]
4348,27569,CHEMBL434394,"Nebivolol (BAN, INN, USAN); Nebivolol HCl (FDA, USAN)",4,R-65824; Ro-67555,Janssen; Forest Laboratories Inc,-olol,beta-blockers (propranolol type),-olol,1988.0,2007.0,C07AB12,"C07AB12 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, selective]",Antihypertensive (beta-blocker),US-6545040-B1,Synthetic Small Molecule,Y,N,Racemic Mixture,N,Y,N,N,N,Prescription-only,,,,OC(CNCC(O)C1CCc2cc(F)ccc2O1)C3CCc4cc(F)ccc4O3,<rdkit.Chem.rdchem.Mol object at 0x7f91dc12a040>,[0. 1. 0. ... 0. 0. 0.]
4415,1354,CHEMBL423,"Betaxolol (BAN, INN); Betaxolol HCl (FDA, JAN, USAN, USP)",4,ALO-1401-02; SL 75.212-10; SL-75212-10,Sanofi Aventis Us Llc; Alcon Laboratories Inc,-olol,beta-blockers (propranolol type),-olol,1983.0,1985.0,S01ED02; C07AB05; S01ED52,"S01ED02 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Beta blocking agents1)]; C07AB05 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, selective]; S01ED52 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Beta blocking agents1)]",Anti-Anginal; Antihypertensive,,Synthetic Small Molecule,Y,N,Racemic Mixture,N,Y,N,Y,N,Prescription-only,,,,CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc125d60>,[0. 1. 0. ... 0. 0. 0.]
4432,650126,CHEMBL1173655,"Afatinib (INN, USAN); Afatinib Dimaleate (FDA, USAN)",4,BIBW-2992; BIBW2992-MA2,Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim,-tinib,tyrosine kinase inhibitors,-tinib,2010.0,2013.0,L01XE13,L01XE13 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors],,US-6251912-B1,Synthetic Small Molecule,Y,N,Single Stereoisomer,N,Y,N,N,N,Prescription-only,,,,CN(C)C\C=C\C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]4CCOC4,<rdkit.Chem.rdchem.Mol object at 0x7f91dc125ac0>,[0. 0. 0. ... 0. 0. 0.]
4521,340684,CHEMBL204656,"Elvitegravir (FDA, INN, USAN)",4,GS-9137; JTK-303,Gilead Sciences Inc,-vir,antivirals: integrase inhibitors,-vir (-tegravir),2007.0,2012.0,J05AX11,J05AX11 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Other antivirals],,US-5814639-A,Synthetic Small Molecule,Y,N,Single Stereoisomer,N,Y,N,N,N,Prescription-only,,,,COc1cc2N(C=C(C(=O)O)C(=O)c2cc1Cc3cccc(Cl)c3F)[C@H](CO)C(C)C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc125580>,[0. 1. 0. ... 0. 0. 0.]
4769,691562,CHEMBL1229211,"Dolutegravir (INN, USAN); Dolutegravir Sodium (FDA, USAN)",4,GSK1349572; S-349572; GSK1349572A,Viiv Hlthcare; Viiv Healthcare Co; GlaxoSmithKline,-vir,antivirals: integrase inhibitors,-vir (-tegravir),2010.0,2013.0,J05AX12,J05AX12 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Other antivirals],,US-5905082-A,Synthetic Small Molecule,Y,N,Single Stereoisomer,N,Y,N,N,N,Prescription-only,,,,C[C@@H]1CCO[C@H]2CN3C=C(C(=O)NCc4ccc(F)cc4F)C(=O)C(=C3C(=O)N12)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc1253c0>,[0. 0. 0. ... 0. 0. 0.]
5218,789,CHEMBL13,"Metoprolol (BAN, INN, USAN); Metoprolol Tartrate (FDA, JAN, USAN, USP); Metoprolol Succinate (FDA, USAN, USP); Metoprolol Fumarate (FDA, USAN, USP)",4,CGP-2175E; H 93/26 Succinate; H-93/26; CGP-2175C,Us Pharmaceuticals Holdings I Llc; Novartis Pharmaceuticals Corp; Astrazeneca Lp,-olol,beta-blockers (propranolol type),-olol,1976.0,1978.0,C07AB02; C07AB52,"C07AB02 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, selective]; C07AB52 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, selective]",Anti-Adrenergic (beta-receptor); Anti-Anginal; Antihypertensive,,Synthetic Small Molecule,Y,N,Racemic Mixture,N,Y,Y,N,Y,Prescription-only,,,,COCCc1ccc(OCC(O)CNC(C)C)cc1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc120970>,[0. 1. 0. ... 0. 0. 0.]
5226,32027,CHEMBL698,"Amethocaine (BAN); Tetracaine (BAN, FDA, INN, USP); Amethocaine HCl (BAN); Tetracaine HCl (BAN, JAN, USP); Tetracaine hydrochloride (FDA)",4,,"Galderma Laboratories Lp; Ciba Vision, Us Ophthalmics; Alcon Research Ltd; Alcon; Sterling Winthrop",-caine,local anesthetics,-caine,,2005.0,N01BA03; C05AD02; D04AB06; S01HA03,"N01BA03 [Nervous System:Anesthetics:Anesthetics, Local:Esters of aminobenzoic acid]; C05AD02 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Local anesthetics]; D04AB06 [Dermatologicals:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Anesthetics for topical use]; S01HA03 [Sensory Organs:Ophthalmologicals:Local Anesthetics:Local anesthetics]",Anesthetic (local); Anesthetic (topical),US-5658583-A,Synthetic Small Molecule,Y,Y,Achiral Molecule,N,N,N,Y,N,Prescription-only,,,,CCCCNc1ccc(cc1)C(=O)OCCN(C)C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc120820>,[0. 0. 0. ... 0. 0. 0.]
5238,305519,CHEMBL174,"Ampicillin (BAN, INN, JAN, USAN, USP); Ampicillin/Ampicillin Trihydrate (FDA); Ampicillin Sodium (FDA, JAN, USAN, USP)",4,AY-6108; BRL-1341; P-50,Wyeth Ayerst Laboratories; Pfizer Inc.; Bristol Laboratories Inc Div Bristol Myers Co; Apothecon Sub Bristol Myers Squibb Co,-cillin,penicillins,-cillin,1962.0,1965.0,J01CA51; J01CA01; S01AA19,"J01CA51 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Penicillins with extended spectrum]; J01CA01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Penicillins with extended spectrum]; S01AA19 [Sensory Organs:Ophthalmologicals:Antiinfectives:Antibiotics]",Antibacterial,,Natural Product-derived,Y,N,Single Stereoisomer,N,Y,Y,N,N,Prescription-only,,,,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc1205f0>,[0. 1. 0. ... 0. 0. 0.]
5243,2039176,CHEMBL3707205,(2-Benzhydryloxyethyl)Diethyl-Methylammonium Iodide,4,,,-ium,quaternary ammonium derivatives,-ium,,,A03AB16,"A03AB16 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Synthetic anticholinergics, quaternary ammonium compounds]",,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,N,N,N,N,Unknown,,,,CC[N+](C)(CC)CCOC(c1ccccc1)c2ccccc2,<rdkit.Chem.rdchem.Mol object at 0x7f91dc120510>,[0. 1. 0. ... 0. 0. 0.]
5476,1788,CHEMBL32,"Moxifloxacin (BAN, INN); Moxifloxacin HCl (FDA, USAN)",4,BAY-128039; BAY-12-8039,Bayer Healthcare Pharmaceuticals Inc; Alcon Pharmaceuticals Ltd,-oxacin,antibacterials (quinolone derivatives),-oxacin,1998.0,1999.0,J01MA14; S01AE07,J01MA14 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones]; S01AE07 [Sensory Organs:Ophthalmologicals:Antiinfectives:Fluoroquinolones],,US-5849752-A,Synthetic Small Molecule,Y,N,Single Stereoisomer,N,Y,Y,Y,Y,Prescription-only,,,,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc4C(=O)C(=CN(C5CC5)c14)C(=O)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc11aeb0>,[0. 0. 0. ... 0. 0. 0.]
5705,27610,CHEMBL654,"Mirtazapine (BAN, FDA, INN, USAN, USP)",4,ORG-3770,Organon Usa Inc,-pin(e),tricyclic compounds,-pin(e),1989.0,1996.0,N06AX11,N06AX11 [Nervous System:Psychoanaleptics:Antidepressants:Other antidepressants],Antidepressant,,Synthetic Small Molecule,Y,N,Racemic Mixture,N,Y,N,N,Y,Prescription-only,,,,CN1CCN2C(C1)c3ccccc3Cc4cccnc24,<rdkit.Chem.rdchem.Mol object at 0x7f91dc11a970>,[0. 0. 0. ... 0. 0. 0.]
5707,208978,CHEMBL1195,"Propoxycaine (INN); Propoxycaine HCl (FDA, USP)",4,,Eastman Kodak Co,-caine,local anesthetics,-caine,,1982.0,,,Anesthetic (local),,Synthetic Small Molecule,Y,N,Achiral Molecule,N,N,Y,N,N,Discontinued,,,,CCCOc1cc(N)ccc1C(=O)OCCN(CC)CC,<rdkit.Chem.rdchem.Mol object at 0x7f91dc11a900>,[0. 0. 0. ... 0. 0. 0.]
5816,675265,CHEMBL1201314,"Valganciclovir (BAN, INN); Valganciclovir HCl (FDA, USAN)",4,Ro-1079070/194; RS-079070-194,Hoffmann La Roche Inc,-vir,antivirals: antivirals (acyclovir type),-vir (-ciclovir),1997.0,2001.0,J05AB14,J05AB14 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleosides and nucleotides excl. reverse transcriptase inhibitors],Antiviral,US-6083953-A,Natural Product-derived,Y,N,Racemic Mixture,Y,Y,N,N,Y,Prescription-only,,,,CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2C(=O)N=C(N)Nc12,<rdkit.Chem.rdchem.Mol object at 0x7f91dc11a820>,[0. 1. 0. ... 0. 1. 0.]
5849,24806,CHEMBL615,"Penicillin V (FDA, USAN, USP); Phenoxymethylpenicillin (BAN, INN); Penicillin V Potassium (FDA, USAN, USP); Phenoxymethylpenicillin Potassium (JAN); Bicillin V2 (JAN); Penicillin V Benzathine (USAN, USP)",4,,Aurobindo Pharma Ltd; Apothecon Sub Bristol Myers Squibb Co; Apothecon Inc Div Bristol Myers Squibb; American Antibiotics Llc; Eli Lilly And Co,-cillin,penicillins,-cillin,1975.0,1958.0,J01CE02; J01CE10,"J01CE02 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Beta-lactamase sensitive penicillins]; J01CE10 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Beta-lactamase sensitive penicillins]",Antibacterial,,Natural Product-derived,Y,N,Single Stereoisomer,N,Y,N,N,N,Prescription-only,,,,CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc11a7b0>,[0. 0. 0. ... 0. 0. 0.]
5975,1615,CHEMBL29,"Benzylpenicillin (BAN, INN, MI); Benzylpenicillin Potassium (BAN, JAN); Penicillin G potassium (FDA, USP); Benzylpenicillin Sodium (BAN); Penicillin g sodium (FDA, USP); Benzathine Benzylpenicillin (BAN, INN); Benzathine Penicillin (BAN); Benzylpenicillin Benzathine (JAN); Penicillin G Benzathine (FDA, USP); Benethamine Penicillin (BAN, INN); Penicillin Calcium (USP)",4,,King Pharmaceuticals Inc; John D Copanos And Co Inc; Bristol Myers Squibb Spa; Baxter Healthcare Corp; Pharmacia And Upjohn Co,-cillin,penicillins,-cillin,,1947.0,J01CE01; S01AA14; J01CE08,"J01CE01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Beta-lactamase sensitive penicillins]; S01AA14 [Sensory Organs:Ophthalmologicals:Antiinfectives:Antibiotics]; J01CE08 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Beta-lactamase sensitive penicillins]",Antibacterial,,Natural Product-derived,Y,N,Single Stereoisomer,N,Y,Y,N,Y,Prescription-only,,,,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc11a270>,[0. 0. 0. ... 0. 0. 0.]
6250,57175,CHEMBL826,"Enoxacin (BAN, FDA, INN, JAN, USAN)",4,AT-2266; CI-919; PD-107779,Sanofi Aventis Us Llc,-oxacin,antibacterials (quinolone derivatives),-oxacin,1984.0,1991.0,J01MA04,J01MA04 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones],Antibacterial,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,N,N,Discontinued,,,,CCN1C=C(C(=O)O)C(=O)c2cc(F)c(nc12)N3CCNCC3,<rdkit.Chem.rdchem.Mol object at 0x7f91dc114b30>,[0. 0. 0. ... 0. 0. 0.]
6251,675067,CHEMBL1201116,"Hetacillin (BAN, FDA, INN, USAN, USP); Hetacillin Potassium (FDA, JAN, USAN, USP)",4,BL-P-804; BRL-804,Bristol Laboratories Inc Div Bristol Myers Co,-cillin,penicillins,-cillin,1965.0,1982.0,J01CA18,"J01CA18 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Penicillins with extended spectrum]",Antibacterial,,Natural Product-derived,Y,N,Single Stereoisomer,Y,Y,N,N,N,Discontinued,,,,CC1(C)S[C@@H]2[C@H](N3C(=O)[C@H](NC3(C)C)c4ccccc4)C(=O)N2[C@H]1C(=O)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc114ac0>,[0. 0. 0. ... 0. 0. 1.]
6257,378225,CHEMBL1449,"Ticarcillin (BAN, INN); Ticarcillin Disodium (FDA, USAN, USP); Ticarcillin Sodium (JAN); Ticarcillin Monosodium (USP)",4,BRL-2288,GlaxoSmithKline,-cillin,penicillins,-cillin,1973.0,1976.0,J01CA13,"J01CA13 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Penicillins with extended spectrum]",Antibacterial,,Natural Product-derived,Y,N,Single Stereoisomer,N,N,Y,N,N,Prescription-only,,,,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](C(=O)O)c3ccsc3)C(=O)N2[C@H]1C(=O)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc1149e0>,[0. 1. 0. ... 0. 0. 0.]
6472,14406,CHEMBL550,"Pilocarpine (BAN, FDA, JAN, USP); Pilocarpine Nitrate (USP); Pilocarpine HCl (FDA, JAN, USP)",4,,Allergan; Alcon Research Ltd; Alcon Laboratories Inc; Akorn Inc; Eisai Inc,-pin(e),tricyclic compounds,-pin(e),,1974.0,S01EB01; N07AX01; S01EB51,S01EB01 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Parasympathomimetics]; N07AX01 [Nervous System:Other Nervous System Drugs:Parasympathomimetics:Other parasympathomimetics]; S01EB51 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Parasympathomimetics],Antiglaucoma Agent; Cholinergic (ophthalmic),,Synthetic Small Molecule,Y,N,Single Stereoisomer,N,Y,N,Y,N,Prescription-only,,,,CC[C@H]1[C@@H](Cc2cncn2C)COC1=O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc1146d0>,[0. 0. 0. ... 0. 0. 0.]
6473,150423,CHEMBL1093,"Articaine (BAN, INN); Articaine HCl (FDA, USAN)",4,HOE-045; 40045,Pierrel S.P.A.; Deproco Inc,-caine,local anesthetics,-caine,1998.0,2000.0,N01BB08; N01BB58,"N01BB08 [Nervous System:Anesthetics:Anesthetics, Local:Amides]; N01BB58 [Nervous System:Anesthetics:Anesthetics, Local:Amides]",,,Synthetic Small Molecule,Y,N,Racemic Mixture,N,N,Y,N,N,Prescription-only,,,,CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC,<rdkit.Chem.rdchem.Mol object at 0x7f91dc114660>,[0. 1. 0. ... 0. 0. 0.]
6543,27570,CHEMBL649,"Nadolol (BAN, FDA, INN, JAN, USAN, USP)",4,SQ-11725,King Pharmaceuticals Inc,-olol,beta-blockers (propranolol type),-olol,1976.0,1979.0,C07AA12,"C07AA12 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, non-selective]",Anti-Adrenergic (beta-receptor),,Synthetic Small Molecule,Y,N,Racemic Mixture,N,Y,N,N,Y,Prescription-only,,,,CC(C)(C)NCC(O)COc1cccc2C[C@@H](O)[C@@H](O)Cc12,<rdkit.Chem.rdchem.Mol object at 0x7f91dc114430>,[0. 1. 0. ... 0. 0. 0.]
6629,1380095,CHEMBL2107825,"Tenofovir Alafenamide (USAN); Tenofovir alafenamide fumarate (FDA, USAN)",4,GS-7340; GS-734003,"Gilead Sciences, Inc.; Gilead Sciences Inc",-vir,antivirals,-vir,2012.0,2015.0,,,,US-5814639-A,Natural Product-derived,Y,N,Single Stereoisomer,Y,Y,N,N,Y,Prescription-only,,,,CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)Cn1cnc2c(N)ncnc12)Oc3ccccc3,<rdkit.Chem.rdchem.Mol object at 0x7f91dc114270>,[0. 1. 0. ... 0. 0. 0.]
6737,430506,CHEMBL1537,"Azlocillin (BAN, INN, USAN); Azlocillin Sodium (FDA, USP)",4,,Bayer Pharmaceuticals Corp; Bayer,-cillin,penicillins,-cillin,1976.0,1982.0,J01CA09,"J01CA09 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Penicillins with extended spectrum]",Antibacterial,,Natural Product-derived,Y,N,Single Stereoisomer,N,N,Y,N,N,Discontinued,,,,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c4ccccc4)C(=O)N2[C@H]1C(=O)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc110dd0>,[0. 1. 0. ... 0. 0. 0.]
6750,673030,CHEMBL1199080,"Bretylium Tosilate (BAN, INN); Bretylium Tosylate (FDA, USAN, USP)",4,ASL-603,"Hospira Inc; Baxter Healthcare Corp; B Braun Medical Inc; Abbott Laboratories Pharmaceutical Products Div; Hospira Worldwide, Inc",-ium,quaternary ammonium derivatives,-ium,1976.0,1986.0,C01BD02,"C01BD02 [Cardiovascular System:Cardiac Therapy:Antiarrhythmics, Class I And Iii:Antiarrhythmics, class III]",Anti-Adrenergic; Cardiac Depressant (anti-arrhythmic),,Synthetic Small Molecule,Y,N,Achiral Molecule,N,N,Y,N,N,Prescription-only,,,,CC[N+](C)(C)Cc1ccccc1Br,<rdkit.Chem.rdchem.Mol object at 0x7f91dc110c80>,[0. 0. 0. ... 0. 0. 0.]
6908,365284,CHEMBL182,"Ganciclovir (BAN, FDA, INN, JAN, USAN, USP); Ganciclovir sodium (FDA, USAN)",4,BW-759U; RS-21592; RS-21592 Sodium,Roche Palo Alto Llc; Bausch And Lomb Inc,-vir,antivirals: antivirals (acyclovir type),-vir (-ciclovir),1987.0,1989.0,J05AB06; S01AD09,J05AB06 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleosides and nucleotides excl. reverse transcriptase inhibitors]; S01AD09 [Sensory Organs:Ophthalmologicals:Antiinfectives:Antivirals],Antiviral,,Natural Product-derived,Y,N,Achiral Molecule,Y,Y,Y,Y,Y,Prescription-only,,,,Nc1nc(O)c2ncn(COC(CO)CO)c2n1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc110900>,[0. 1. 0. ... 0. 0. 0.]
6977,685299,CHEMBL1213456,Nemonoxacin,4,TG-873870,,-oxacin,antibacterials (quinolone derivatives),-oxacin,,,J01MB08,J01MB08 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Other quinolones],,,Synthetic Small Molecule,Y,N,Single Stereoisomer,N,N,N,N,N,Unknown,,,,COc1c(ccc2C(=O)C(=CN(C3CC3)c12)C(=O)O)N4C[C@@H](C)C[C@H](N)C4,<rdkit.Chem.rdchem.Mol object at 0x7f91dc1107b0>,[0. 0. 0. ... 0. 0. 0.]
6998,16278,CHEMBL561,"Lomefloxacin (BAN, INN, USAN); Lomefloxacin HCl (FDA, JAN, USAN); Lomefloxacin Mesylate (USAN)",4,SC-47111A; NY-198; SC-47111; SC-47111B,Pharmacia Corp,-oxacin,antibacterials (quinolone derivatives),-oxacin,1988.0,1992.0,J01MA07; S01AE04,J01MA07 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones]; S01AE04 [Sensory Organs:Ophthalmologicals:Antiinfectives:Fluoroquinolones],Antibacterial,,Synthetic Small Molecule,Y,N,Racemic Mixture,N,Y,N,N,N,Discontinued,,,,CCN1C=C(C(=O)O)C(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c12,<rdkit.Chem.rdchem.Mol object at 0x7f91dc110270>,[0. 0. 0. ... 0. 0. 0.]
7068,27417,CHEMBL645,"Bisoprolol (BAN, INN, USAN); Bisoprolol Fumarate (FDA, JAN, USAN, USP)",4,CL-297939; EMD-33512; EMD-33-512,Teva Womens Health Inc,-olol,beta-blockers (propranolol type),-olol,1987.0,1992.0,C07AB57; C07AB07,"C07AB57 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, selective]; C07AB07 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, selective]",Antihypertensive (beta-blocker),,Synthetic Small Molecule,Y,N,Racemic Mixture,N,Y,N,N,N,Prescription-only,,,,CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc1100b0>,[0. 1. 0. ... 0. 0. 0.]
7100,675276,CHEMBL1201325,"Hexocyclium Methylsulfate (FDA, MI); Hexocyclium Metilsulfate (BAN, INN)",4,,Abbvie Inc,-ium,quaternary ammonium derivatives,-ium,,1982.0,A03AB10,"A03AB10 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Drugs For Functional Gastrointestinal Disorders:Synthetic anticholinergics, quaternary ammonium compounds]",,,Synthetic Small Molecule,Y,N,Racemic Mixture,N,Y,N,N,N,Discontinued,,,,C[N+]1(C)CCN(CC(O)(C2CCCCC2)c3ccccc3)CC1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc10bf90>,[0. 0. 1. ... 0. 0. 0.]
7129,16580,CHEMBL276520,"Indalpine (BAN, INN, MI)",4,LM-5008,,-pin(e),tricyclic compounds,-pin(e),,,,,,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,N,N,N,N,Withdrawn,1985.0,France,Agranulocytosis,C(Cc1c[nH]c2ccccc12)C3CCNCC3,<rdkit.Chem.rdchem.Mol object at 0x7f91dc10bf20>,[0. 0. 0. ... 0. 0. 0.]
7567,16716,CHEMBL575,"Methicillin (BAN); Meticillin (INN); Methicillin sodium (FDA, USAN, USP); Meticillin Sodium (JAN)",4,BRL-1241; SQ-16123; X-1497,Apothecon Inc Div Bristol Myers Squibb,-cillin,penicillins,-cillin,1962.0,1982.0,J01CF03,"J01CF03 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Beta-lactamase resistant penicillins]",Antibacterial,,Natural Product-derived,Y,N,Single Stereoisomer,N,N,Y,N,N,Discontinued,,,,COc1cccc(OC)c1C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc10b970>,[0. 0. 0. ... 0. 0. 0.]
7657,255221,CHEMBL1291,"Metipranolol (BAN, INN, USAN); Metipranolol HCl (FDA)",4,BM-01004; VUAB-6453; VUAB6453 (SPOFA),Bausch And Lomb Pharmaceuticals Inc; Bausch & Lomb Pharmaceuticals,-olol,beta-blockers (propranolol type),-olol,1990.0,1989.0,S01ED04; S01ED54,S01ED04 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Beta blocking agents1)]; S01ED54 [Sensory Organs:Ophthalmologicals:Antiglaucoma Preparations And Miotics:Beta blocking agents1)],"Antihypertensive (beta-blocker, ophthalmic)",,Synthetic Small Molecule,Y,N,Racemic Mixture,Y,N,N,Y,N,Prescription-only,1990.0,United Kingdom,Uveitis,CC(C)NCC(O)COc1cc(C)c(OC(=O)C)c(C)c1C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc10b890>,[0. 1. 0. ... 0. 0. 0.]
8159,1279,CHEMBL24,"Atenolol (BAN, FDA, INN, JAN, USAN, USP)",4,ICI-66082,Astrazeneca Pharmaceuticals Lp; Astrazeneca Lp,-olol,beta-blockers (propranolol type),-olol,1976.0,1981.0,C07AB03,"C07AB03 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, selective]",Anti-Adrenergic (beta-receptor),,Synthetic Small Molecule,Y,N,Racemic Mixture,N,Y,Y,N,Y,Prescription-only,,,,CC(C)NCC(O)COc1ccc(CC(=O)N)cc1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc10b350>,[0. 1. 0. ... 0. 0. 0.]
8262,6883,CHEMBL492,"Etidocaine (BAN, INN, USAN); Etidocaine HCl (FDA)",4,W-19053,Dentsply Pharmaceutical; Astrazeneca Lp; Astra,-caine,local anesthetics,-caine,1973.0,1976.0,N01BB07; N01BB57,"N01BB07 [Nervous System:Anesthetics:Anesthetics, Local:Amides]; N01BB57 [Nervous System:Anesthetics:Anesthetics, Local:Amides]",Anesthetic (local),,Synthetic Small Molecule,Y,N,Racemic Mixture,N,N,Y,N,N,Discontinued,,,,CCCN(CC)C(CC)C(=O)Nc1c(C)cccc1C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc10b190>,[0. 1. 0. ... 0. 0. 0.]
8361,2039202,CHEMBL3707231,Fluclorolone,4,,,-olone,steroids (not prednisolone derivatives),-olone,,,D07AC02,"D07AC02 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, potent (group III)]",,,Natural Product-derived,Y,N,Single Stereoisomer,N,N,N,N,N,Unknown,,,,C[C@]12C[C@H](Cl)[C@@]3(Cl)[C@@H](C[C@H](F)C4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO,<rdkit.Chem.rdchem.Mol object at 0x7f91dc107f20>,[0. 0. 0. ... 0. 0. 0.]
8416,367860,CHEMBL221959,"Tofacitinib (INN, USAN); Tofacitinib Citrate (FDA, USAN)",4,CP-690; CP-690550; CP-690550-10,Pfizer Inc.,-tinib,tyrosine kinase inhibitors,-tinib,2010.0,2012.0,L04AA29,L04AA29 [Antineoplastic And Immunomodulating Agents:Immunosuppressants:Immunosuppressants:Selective immunosuppressants],,US-6956041-B2; US-6956027-B2,Synthetic Small Molecule,Y,N,Single Stereoisomer,N,Y,N,N,Y,Prescription-only,,,,C[C@@H]1CCN(C[C@@H]1N(C)c2ncnc3[nH]ccc23)C(=O)CC#N,<rdkit.Chem.rdchem.Mol object at 0x7f91dc107d60>,[0. 0. 1. ... 0. 0. 0.]
8424,151408,CHEMBL1104,"Edrophonium Chloride (BAN, FDA, INN, JAN, USP)",4,,Valeant Pharmaceuticals International; Mylan Institutional Llc,-ium,quaternary ammonium derivatives,-ium,,1951.0,,,Antidote (to curare principles); Diagnostic Aid (myasthenia gravis),,Synthetic Small Molecule,Y,N,Achiral Molecule,N,N,Y,N,N,Prescription-only,,,,CC[N+](C)(C)c1cccc(O)c1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc107c10>,[0. 0. 0. ... 0. 0. 0.]
8427,209162,CHEMBL1197,"Hexylcaine (INN); Hexylcaine HCl (FDA, USP)",4,,Merck And Co Inc,-caine,local anesthetics,-caine,,1982.0,,,,,Synthetic Small Molecule,Y,N,Racemic Mixture,N,N,N,Y,N,Discontinued,,,,CC(CNC1CCCCC1)OC(=O)c2ccccc2,<rdkit.Chem.rdchem.Mol object at 0x7f91dc107ba0>,[0. 1. 1. ... 0. 0. 0.]
8480,674999,CHEMBL1201048,"Dromostanolone Propionate (FDA, USAN, USP); Drostanolone (BAN, INN); Drostanolone Propionate (JAN)",4,32379,Eli Lilly And Co,-olone,steroids (not prednisolone derivatives),-olone,1963.0,1982.0,,,Antineoplastic,,Natural Product-derived,Y,N,Single Stereoisomer,Y,N,Y,N,N,Discontinued,,,,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)[C@H](C)C[C@]4(C)[C@H]3CC[C@]12C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc1079e0>,[0. 0. 0. ... 0. 0. 0.]
8685,1795,CHEMBL33,"Levofloxacin (BAN, FDA, INN, JAN, USAN)",4,DR-3355; RWJ-25213,Santen Inc; Janssen Pharmaceuticals Inc,-oxacin,antibacterials (quinolone derivatives),-oxacin,1996.0,1996.0,J01MA12; S01AE05,J01MA12 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones]; S01AE05 [Sensory Organs:Ophthalmologicals:Antiinfectives:Fluoroquinolones],Antibacterial,US-6806256-B2,Synthetic Small Molecule,Y,N,Single Stereoisomer,N,Y,Y,Y,Y,Prescription-only,,,,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc4C(=O)C(=CN1c24)C(=O)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc107580>,[0. 0. 0. ... 1. 0. 0.]
8687,1159,CHEMBL21,"Sulfanilamide (DCF, FDA, INN, MI, NF)",4,,Meda Pharmaceuticals Inc,sulfa-,antimicrobials (sulfonamides derivatives),sulfa-,,1985.0,J01EB06; D06BA05,J01EB06 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Short-acting sulfonamides]; D06BA05 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Sulfonamides],,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,N,N,Y,N,Prescription-only,,,,Nc1ccc(cc1)S(=O)(=O)N,<rdkit.Chem.rdchem.Mol object at 0x7f91dc1074a0>,[0. 0. 0. ... 0. 0. 0.]
8959,254975,CHEMBL1290,"Penbutolol (BAN, INN); Penbutolol Sulfate (FDA, JAN, USAN, USP)",4,HOE-39-893d; HOE-893d,Actient Pharmaceuticals Llc,-olol,beta-blockers (propranolol type),-olol,1977.0,1987.0,C07AA23,"C07AA23 [Cardiovascular System:Beta Blocking Agents:Beta Blocking Agents:Beta blocking agents, non-selective]",Anti-Adrenergic (beta-receptor),,Synthetic Small Molecule,Y,N,Single Stereoisomer,N,Y,N,N,N,Prescription-only,,,,CC(C)(C)NC[C@H](O)COc1ccccc1C2CCCC2,<rdkit.Chem.rdchem.Mol object at 0x7f91dc107350>,[0. 1. 0. ... 0. 0. 0.]
9085,247401,CHEMBL1271,"Pentolinium Tartrate (FDA, MI, NF); Pentolonium Tartrate (BAN, INN)",4,,Wyeth Ayerst Laboratories,-ium,quaternary ammonium derivatives,-ium,,1982.0,,,,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,N,Y,N,N,Discontinued,,,,C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc107200>,[0. 0. 0. ... 0. 0. 0.]
9432,1383575,CHEMBL2111135,"Thiazinamium Chloride (USAN); Thiazinamium Metilsulfate (INN, MI)",4,WY-460E,,-ium,quaternary ammonium derivatives,-ium,1978.0,,R06AD06,R06AD06 [Respiratory System:Antihistamines For Systemic Use:Antihistamines For Systemic Use:Phenothiazine derivatives],Anti-Allergic,,Synthetic Small Molecule,Y,N,Racemic Mixture,N,N,N,N,N,Unknown,,,,CC(CN1c2ccccc2Sc3ccccc13)[N+](C)(C)C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc181d60>,[0. 1. 0. ... 0. 0. 0.]
9463,12465,CHEMBL530,"Amdinocillin (FDA, USAN, USP); Mecillinam (BAN, INN)",4,Ro-109070,Hoffmann La Roche Inc,-cillin,penicillins,-cillin,1981.0,1984.0,J01CA11,"J01CA11 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Penicillins with extended spectrum]",Antibacterial,,Natural Product-derived,Y,N,Single Stereoisomer,N,N,Y,N,N,Discontinued,,,,CC1(C)S[C@@H]2[C@H](\N=C\N3CCCCCC3)C(=O)N2[C@H]1C(=O)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc181cf0>,[0. 0. 1. ... 0. 0. 0.]
9470,139940,CHEMBL87992,"Eslicarbazepine Acetate (FDA, USAN)",4,BIA-2-093; SEP-0002093,Sunovion Pharmaceuticals Inc,-pin(e),tricyclic compounds,-pin(e),2008.0,2009.0,N03AF04,N03AF04 [Nervous System:Antiepileptics:Antiepileptics:Carboxamide derivatives],,US-5753646-A,Synthetic Small Molecule,Y,N,Single Stereoisomer,Y,Y,N,N,N,Prescription-only,,,,CC(=O)O[C@H]1Cc2ccccc2N(C(=O)N)c3ccccc13,<rdkit.Chem.rdchem.Mol object at 0x7f91dc181c80>,[0. 0. 0. ... 0. 0. 0.]
9713,453719,CHEMBL1583,"Bacampicillin (BAN, INN); Bacampicillin HCl (FDA, JAN, USAN, USP)",4,,Pfizer Laboratories Div Pfizer Inc,-cillin,penicillins,-cillin,1977.0,1980.0,J01CA06,"J01CA06 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Penicillins with extended spectrum]",Antibacterial,,Natural Product-derived,Y,N,Racemic Mixture,Y,Y,N,N,N,Discontinued,,,,CCOC(=O)OC(C)OC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](NC(=O)[C@H](N)c3ccccc3)C2=O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc181970>,[0. 1. 0. ... 0. 0. 0.]
9728,674307,CHEMBL1200356,"Ciclacillin (BAN, INN, JAN); Cyclacillin (FDA, USAN, USP)",4,WY-4508,Wyeth Ayerst Laboratories,-cillin,penicillins,-cillin,1969.0,1979.0,,,Antibacterial,,Natural Product-derived,Y,N,Single Stereoisomer,N,Y,N,N,N,Discontinued,,,,CC1(C)S[C@@H]2[C@H](NC(=O)C3(N)CCCCC3)C(=O)N2[C@H]1C(=O)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc181900>,[0. 0. 1. ... 0. 0. 0.]
9737,422253,CHEMBL254316,"Raltegravir (INN, USAN); Raltegravir Potassium (FDA, USAN)",4,MK-0518,Merck Sharp And Dohme Corp; Merck & Co,-vir,antivirals: integrase inhibitors,-vir (-tegravir),2007.0,2007.0,J05AX08,J05AX08 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Other antivirals],,US-7169780-B2,Synthetic Small Molecule,Y,Y,Achiral Molecule,N,Y,N,N,N,Prescription-only,,,,CN1C(=O)C(=C(N=C1C(C)(C)NC(=O)c2oc(C)nn2)C(=O)NCc3ccc(F)cc3)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc181890>,[0. 0. 0. ... 0. 0. 0.]
9803,361469,CHEMBL1421,"Dasatinib (FDA, INN, USAN)",4,BMS-354825; BMS-354825-03,Bristol Myers Squibb Co,-tinib,tyrosine kinase inhibitors,-tinib,2005.0,2006.0,L01XE06,L01XE06 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors],,US-6596746-B1,Synthetic Small Molecule,Y,Y,Achiral Molecule,N,Y,N,N,N,Prescription-only,,,,Cc1nc(Nc2ncc(s2)C(=O)Nc3c(C)cccc3Cl)cc(n1)N4CCN(CCO)CC4,<rdkit.Chem.rdchem.Mol object at 0x7f91dc181820>,[0. 0. 0. ... 0. 0. 0.]
9826,77085,CHEMBL893,"Dicloxacillin (BAN, INN, USAN); Dicloxacillin Sodium (BAN, FDA, JAN, USAN, USP)",4,BRL-1702; R-13423; P-1011,Wyeth Ayerst Laboratories; Apothecon Inc Div Bristol Myers Squibb,-cillin,penicillins,-cillin,1965.0,1968.0,J01CF01,"J01CF01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Beta-Lactam Antibacterials, Penicillins:Beta-lactamase resistant penicillins]",Antibacterial,,Natural Product-derived,Y,N,Single Stereoisomer,N,Y,N,N,N,Prescription-only,,,,Cc1onc(c1C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O)c4c(Cl)cccc4Cl,<rdkit.Chem.rdchem.Mol object at 0x7f91dc1817b0>,[0. 0. 0. ... 0. 0. 0.]
9856,949710,CHEMBL1525826,"Sulfalene (INN, USAN); Sulfamethopyrazine (JAN); Sulfametopyrazine (BAN, DCF)",4,,"Farmitalia, Societa Farmaceutici Italia, Italy; Abbott",sulfa-,antimicrobials (sulfonamides derivatives),sulfa-,1965.0,,J01ED02,J01ED02 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Long-acting sulfonamides],Antibacterial,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,N,N,Discontinued,,,,COc1nccnc1NS(=O)(=O)c2ccc(N)cc2,<rdkit.Chem.rdchem.Mol object at 0x7f91dc181510>,[0. 0. 0. ... 0. 0. 0.]
10151,34197,CHEMBL715,"Olanzapine (BAN, FDA, INN, USAN); Olanzapine Pamoate (FDA, USAN)",4,LY-170053,Eli Lilly Co; Eli Lilly And Co,-pin(e),tricyclic compounds,-pin(e),1992.0,1996.0,N05AH03,"N05AH03 [Nervous System:Psycholeptics:Antipsychotics:Diazepines, oxazepines, thiazepines and oxepines]",Antipsychotic,US-5945416-A,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,Y,N,Y,Prescription-only,,,,CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24,<rdkit.Chem.rdchem.Mol object at 0x7f91dc17cf90>,[0. 0. 0. ... 0. 0. 0.]
10458,675225,CHEMBL1201274,"Levobetaxolol (INN); Levobetaxolol HCl (FDA, USAN)",4,AL-1577A,Alcon Pharmaceuticals Ltd,-olol,beta-blockers (propranolol type),-olol,1989.0,2000.0,,,Anti-Adrenergic (beta-receptor),,Synthetic Small Molecule,Y,N,Single Stereoisomer,N,N,N,Y,N,Discontinued,,,,CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc17ccf0>,[0. 1. 0. ... 0. 0. 0.]
10995,146,CHEMBL4,"Ofloxacin (BAN, FDA, INN, JAN, USAN, USP)",4,DL-8280; HOE-280,Ortho Mcneil Pharmaceutical Inc; Janssen Pharmaceuticals Inc; Daiichi Pharmaceutical Corp; Allergan Inc,-oxacin,antibacterials (quinolone derivatives),-oxacin,1984.0,1990.0,S01AE01; J01MA01; S02AA16,S01AE01 [Sensory Organs:Ophthalmologicals:Antiinfectives:Fluoroquinolones]; J01MA01 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Quinolone Antibacterials:Fluoroquinolones]; S02AA16 [Sensory Organs:Otologicals:Antiinfectives:Antiinfectives],Antibacterial,,Synthetic Small Molecule,Y,N,Racemic Mixture,N,Y,Y,Y,Y,Prescription-only,,,,CC1COc2c(N3CCN(C)CC3)c(F)cc4C(=O)C(=CN1c24)C(=O)O,<rdkit.Chem.rdchem.Mol object at 0x7f91dc17c740>,[0. 0. 0. ... 1. 0. 0.]
10997,147981,CHEMBL1087,"Mepivacaine (BAN, INN); Mepivacaine HCl (FDA, JAN, USP)",4,,Hospira Inc; Eastman Kodak Co,-caine,local anesthetics,-caine,,1960.0,N01BB03; N01BB53,"N01BB03 [Nervous System:Anesthetics:Anesthetics, Local:Amides]; N01BB53 [Nervous System:Anesthetics:Anesthetics, Local:Amides]",Anesthetic (local),,Synthetic Small Molecule,Y,N,Racemic Mixture,N,N,Y,N,N,Prescription-only,,,,CN1CCCCC1C(=O)Nc2c(C)cccc2C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc17c6d0>,[0. 0. 0. ... 0. 0. 0.]
11103,716009,CHEMBL1289601,"Lenvatinib (INN, USAN); Lenvatinib Mesylate (FDA, USAN)",4,ER-203492-00; E7080,Eisai Inc; Eisai,-tinib,tyrosine kinase inhibitors,-tinib,2010.0,2015.0,L01XE29,L01XE29 [Antineoplastic And Immunomodulating Agents:Antineoplastic Agents:Other Antineoplastic Agents:Protein kinase inhibitors],,US-7253286-B2,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,N,N,Prescription-only,,,,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(=O)N,<rdkit.Chem.rdchem.Mol object at 0x7f91dc17c510>,[0. 0. 0. ... 0. 0. 0.]
11265,155045,CHEMBL1113,"Amoxapine (BAN, FDA, INN, JAN, USAN, USP)",4,CL-67772,Lederle Laboratories Div American Cyanamid Co,-pin(e),tricyclic compounds,-pin(e),1971.0,1980.0,N06AA17,N06AA17 [Nervous System:Psychoanaleptics:Antidepressants:Non-selective monoamine reuptake inhibitors],Antidepressant,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,N,Y,Prescription-only,,,,Clc1ccc2Oc3ccccc3N=C(N4CCNCC4)c2c1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc17c120>,[0. 0. 0. ... 0. 0. 0.]
11287,2095,CHEMBL437,"Sulfathiazole (BAN, INN, USP); Sulfathiazole (Triple Sulfa) (FDA); Sulfathiazole Sodium (MI, NF)",4,,Ortho Mcneil Pharmaceutical Inc,sulfa-,antimicrobials (sulfonamides derivatives),sulfa-,,1945.0,J01EB07; D06BA02,J01EB07 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Short-acting sulfonamides]; D06BA02 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Sulfonamides],Antibacterial,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,N,N,Y,N,Withdrawn,,United States; United States,,Nc1ccc(cc1)S(=O)(=O)Nc2nccs2,<rdkit.Chem.rdchem.Mol object at 0x7f91dc178d60>,[0. 0. 0. ... 0. 0. 0.]
11288,105252,CHEMBL989,"Fluocinolone (BAN); Fluocinolone Acetonide (FDA, INN, JAN, USAN, USP)",4,,Medimetriks Pharmaceuticals Inc; Hill Dermaceuticals Inc; Galderma Laboratories Lp; Bausch And Lomb Inc,-olone,steroids (not prednisolone derivatives),-olone,1962.0,1963.0,D07AC04; S01BA15; S02BA08; C05AA10,"D07AC04 [Dermatologicals:Corticosteroids, Dermatological Preparations:Corticosteroids, Plain:Corticosteroids, potent (group III)]; S01BA15 [Sensory Organs:Ophthalmologicals:Antiinflammatory Agents:Corticosteroids, plain]; S02BA08 [Sensory Organs:Otologicals:Corticosteroids:Corticosteroids]; C05AA10 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Corticosteroids]",Glucocorticoid,US-6217895-B1,Natural Product-derived,Y,N,Single Stereoisomer,N,N,Y,Y,N,Prescription-only,,,,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,<rdkit.Chem.rdchem.Mol object at 0x7f91dc178cf0>,[0. 0. 0. ... 0. 0. 0.]
11302,652997,CHEMBL1179047,"Chloroprocaine (INN); Chloroprocaine HCl (FDA, USP)",4,,Fresenius Kabi Usa Llc,-caine,local anesthetics,-caine,,1955.0,N01BA04,"N01BA04 [Nervous System:Anesthetics:Anesthetics, Local:Esters of aminobenzoic acid]",Anesthetic (local),,Synthetic Small Molecule,Y,N,Achiral Molecule,N,N,Y,N,N,Prescription-only,,,,CCN(CC)CCOC(=O)c1ccc(N)cc1Cl,<rdkit.Chem.rdchem.Mol object at 0x7f91dc178a50>,[0. 0. 0. ... 0. 0. 0.]
11304,26351,CHEMBL620,"Clidinium Bromide (BAN, FDA, INN, USAN, USP)",4,Ro-23773,Hoffmann La Roche Inc,-ium,quaternary ammonium derivatives,-ium,1961.0,1982.0,A03CA02,A03CA02 [Alimentary Tract And Metabolism:Drugs For Functional Gastrointestinal Disorders:Antispasmodics In Combination With Psycholeptics:Synthetic anticholinergic agents in combination with psycholeptics],Anticholinergic,,Synthetic Small Molecule,Y,N,Racemic Mixture,N,Y,N,N,N,Discontinued,,,,C[N+]12CCC(CC1)C(C2)OC(=O)C(O)(c3ccccc3)c4ccccc4,<rdkit.Chem.rdchem.Mol object at 0x7f91dc1789e0>,[0. 0. 0. ... 0. 0. 0.]
11326,59519,CHEMBL831,"Loxapine (BAN, FDA, INN, USAN); Loxapine HCl (FDA); Loxapine Succinate (FDA, USAN, USP)",4,CL-62362; SUM 3170; SUM-3170; CL-71563,Watson Laboratories Inc; Alexza Pharmaceuticals Inc,-pin(e),tricyclic compounds,-pin(e),1969.0,1975.0,N05AH01,"N05AH01 [Nervous System:Psycholeptics:Antipsychotics:Diazepines, oxazepines, thiazepines and oxepines]",Tranquilizer (minor),US-6716416-B2,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,Y,Y,Y,Prescription-only,,,,CN1CCN(CC1)C2=Nc3ccccc3Oc4ccc(Cl)cc24,<rdkit.Chem.rdchem.Mol object at 0x7f91dc178740>,[0. 0. 0. ... 0. 0. 0.]
11354,1228747,CHEMBL1888176,"Trospium Chloride (BAN, FDA, INN, JAN, MI, USAN)",4,IP631,Allergan Inc,-ium,quaternary ammonium derivatives,-ium,2001.0,2004.0,G04BD09,G04BD09 [Genito Urinary System And Sex Hormones:Urologicals:Urologicals:Drugs for urinary frequency and incontinence],,US-7410978-B2,Synthetic Small Molecule,Y,N,Racemic Mixture,N,Y,N,N,N,Prescription-only,,,,OC(C(=O)O[C@H]1C[C@H]2CC[C@@H](C1)[N+]23CCCC3)(c4ccccc4)c5ccccc5,<rdkit.Chem.rdchem.Mol object at 0x7f91dc1784a0>,[0. 0. 0. ... 0. 0. 0.]
11371,33889,CHEMBL713,"Entecavir (FDA, INN, USAN)",4,BMS-200475-01; SQ-34676,Bristol Myers Squibb,-vir,antivirals: carbocyclic nucleosides,-vir (-cavir),1999.0,2005.0,J05AF10,J05AF10 [Antiinfectives For Systemic Use:Antivirals For Systemic Use:Direct Acting Antivirals:Nucleoside and nucleotide reverse transcriptase inhibitors],,,Natural Product-derived,Y,N,Single Stereoisomer,Y,Y,N,N,Y,Prescription-only,,,,NC1=Nc2c(ncn2[C@H]3C[C@H](O)[C@@H](CO)C3=C)C(=O)N1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc178350>,[0. 0. 0. ... 0. 0. 0.]
11374,204115,CHEMBL1191,"Sulfamethizole (BAN, FDA, INN, JAN, USP)",4,,Wyeth Ayerst Laboratories,sulfa-,antimicrobials (sulfonamides derivatives),sulfa-,,1953.0,D06BA04; S01AB01; J01EB02; B05CA04,D06BA04 [Dermatologicals:Antibiotics And Chemotherapeutics For Dermatological Use:Chemotherapeutics For Topical Use:Sulfonamides]; S01AB01 [Sensory Organs:Ophthalmologicals:Antiinfectives:Sulfonamides]; J01EB02 [Antiinfectives For Systemic Use:Antibacterials For Systemic Use:Sulfonamides And Trimethoprim:Short-acting sulfonamides]; B05CA04 [Blood And Blood Forming Organs:Blood Substitutes And Perfusion Solutions:Irrigating Solutions:Antiinfectives],Antibacterial,,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,N,N,N,Discontinued,,,,Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1,<rdkit.Chem.rdchem.Mol object at 0x7f91dc178270>,[0. 0. 0. ... 0. 0. 0.]
11378,6723,CHEMBL79,"Lidocaine (FDA, INN, JAN, USP); Lignocaine (BAN); Lidocaine HCl (FDA, JAN, USP); Lignocaine HCl (BAN)",4,,Amphastar Pharmaceuticals Inc; Akorn Inc; Noven Pharmaceuticals Inc; Abraxis Pharmaceutical Products; Abbott Laboratories Pharmaceutical Products Div,-caine,local anesthetics,-caine,,1948.0,S01HA07; N01BB02; C01BB01; N01BB52; R02AD02; C05AD01; D04AB01; S02DA01,"S01HA07 [Sensory Organs:Ophthalmologicals:Local Anesthetics:Local anesthetics]; N01BB02 [Nervous System:Anesthetics:Anesthetics, Local:Amides]; C01BB01 [Cardiovascular System:Cardiac Therapy:Antiarrhythmics, Class I And Iii:Antiarrhythmics, class Ib]; N01BB52 [Nervous System:Anesthetics:Anesthetics, Local:Amides]; R02AD02 [Respiratory System:Throat Preparations:Throat Preparations:Anesthetics, local]; C05AD01 [Cardiovascular System:Vasoprotectives:Agents For Treatment Of Hemorrhoids And Anal :Local anesthetics]; D04AB01 [Dermatologicals:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Antipruritics, Incl. Antihistamines, Anesthetics, Etc.:Anesthetics for topical use]; S02DA01 [Sensory Organs:Otologicals:Other Otologicals:Analgesics and anesthetics]",Anesthetic (topical); Anesthetic (local),US-5658583-A,Synthetic Small Molecule,Y,N,Achiral Molecule,N,Y,Y,Y,Y,Prescription-only,,,,CCN(CC)CC(=O)Nc1c(C)cccc1C,<rdkit.Chem.rdchem.Mol object at 0x7f91dc178190>,[0. 0. 0. ... 0. 0. 0.]
